Teleflex (TFX) 10-Q 2 May 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Apr. 30, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	TFX
Entity Registrant Name	TELEFLEX INCORPORATED
Entity Central Index Key	0000096943
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Smaller Reporting Company	false
Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		46,154,088

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Income Statement [Abstract]
Net revenues	$ 613,584	$ 587,230
Cost of goods sold	268,842	255,960
Gross profit	344,742	331,270
Selling, general and administrative expenses	227,693	215,337
Research and development expenses	27,150	26,027
Restructuring and impairment charges	17,395	3,063
Gain on sale of assets	(2,739)	0
Income from continuing operations before interest and taxes	75,243	86,843
Interest expense	22,692	25,943
Interest income	(339)	(273)
Income from continuing operations before taxes	52,890	61,173
Taxes on income from continuing operations	10,972	6,242
Income from continuing operations	41,918	54,931
Operating income (loss) from discontinued operations	(1,343)	1,235
Benefit on income (loss) from discontinued operations	(322)	(18)
Income (loss) from discontinued operations	(1,021)	1,253
Net income	$ 40,897	$ 56,184
Basic:
Income from continuing operations (in dollars per share)	$ 0.91	$ 1.21
Income (loss) from discontinued operations (in dollars per share)	(0.02)	0.03
Net income (in dollars per share)	0.89	1.24
Diluted:
Income from continuing operations (in dollars per share)	0.89	1.18
Loss from discontinued operations (in dollars per share)	(0.02)	0.02
Net income (in dollars per share)	$ 0.87	$ 1.20
Weighted average common shares outstanding
Basic (in shares)	46,050	45,329
Diluted (in shares)	46,942	46,695

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 40,897	$ 56,184
Other comprehensive (loss) income, net of tax:
Foreign currency translation, net of tax of $0 and $(5,872)	(236)	81,188
Pension and other postretirement benefit plans adjustment, net of tax of $(390) and $(234)	1,229	881
Derivatives qualifying as hedges, net of tax of $(1) and $(211)	(597)	621
Other comprehensive income, net of tax:	396	82,690
Comprehensive income	$ 41,293	$ 138,874

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Statement of Comprehensive Income [Abstract]
Foreign currency translation, tax	$ 0	$ (5,872)
Pension and other postretirement benefits plans adjustment, tax	(390)	(234)
Derivatives qualifying as hedges, tax	$ (1)	$ (211)

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 271,212	$ 357,161
Accounts receivable, net of allowances of $9,225 and $9,348, respectively	375,756	366,286
Inventories, net	445,566	427,778
Prepaid expenses and other current assets	79,595	72,481
Prepaid taxes	10,485	12,463
Total current assets	1,182,614	1,236,169
Property, plant and equipment, net	409,963	432,766
Operating lease assets	112,278
Goodwill	2,247,768	2,246,579
Intangible assets, net	2,274,488	2,325,052
Deferred tax assets	2,500	2,446
Other assets	38,458	34,979
Total assets	6,268,069	6,277,991
Current liabilities
Current borrowings	86,625	86,625
Accounts payable	103,532	106,709
Accrued expenses	93,649	97,551
Current portion of contingent consideration	99,686	136,877
Payroll and benefit-related liabilities	76,261	104,670
Accrued interest	23,245	6,031
Income taxes payable	6,641	5,943
Other current liabilities	31,277	38,050
Total current liabilities	520,916	582,456
Long-term borrowings	2,072,939	2,072,200
Deferred tax liabilities	610,606	608,221
Pension and postretirement benefit liabilities	89,287	92,914
Noncurrent liability for uncertain tax positions	10,833	10,718
Noncurrent contingent consideration	80,676	167,370
Noncurrent operating lease liabilities	100,708
Other liabilities	212,226	204,134
Total liabilities	3,698,191	3,738,013
Commitments and contingencies
Total shareholders' equity	2,569,878	2,539,978
Total liabilities and shareholders' equity	$ 6,268,069	$ 6,277,991

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - Parenthetical - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable, current	$ 9,225	$ 9,348

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Cash flows from operating activities of continuing operations:
Net income	$ 40,897	$ 56,184
Adjustments to reconcile net income to net cash provided by operating activities:
(Income) loss from discontinued operations	1,021	(1,253)
Depreciation expense	15,645	14,832
Amortization expense of intangible assets	37,751	37,816
Amortization expense of deferred financing costs and debt discount	1,179	1,178
Gain on sale of assets	(2,739)	0
Changes in contingent consideration	13,057	9,592
Asset impairment	3,030	0
Stock-based compensation	5,781	4,787
Deferred income taxes, net	2,603	(1,472)
Payments for contingent consideration	(25,935)	0
Other	654	(1,272)
Changes in assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable	(14,102)	(3,402)
Inventories	(19,200)	32
Prepaid expenses and other assets	(11,524)	(3,406)
Accounts payable, accrued expenses and other liabilities	8,856	(27,185)
Income taxes receivable and payable, net	3,192	417
Net cash provided by operating activities from continuing operations	60,166	86,848
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(23,494)	(15,747)
Proceeds from sale of assets	991	0
Payments for businesses and intangibles acquired, net of cash acquired	(1,025)	(3,684)
Net cash used in investing activities from continuing operations	(23,528)	(19,431)
Cash flows from financing activities of continuing operations:
Reduction in borrowings	0	(18,500)
Debt extinguishment, issuance and amendment fees	0	(74)
Net proceeds from share based compensation plans and the related tax impacts	2,242	1,400
Payments for contingent consideration	(110,953)	(91)
Dividends paid	(15,650)	(15,447)
Net cash provided by (used in) financing activities from continuing operations	(124,361)	(32,712)
Cash flows from discontinued operations:
Net cash used in operating activities	3,610	(206)
Net cash used in discontinued operations	3,610	(206)
Effect of exchange rate changes on cash and cash equivalents	(1,836)	10,815
Net (decrease) increase in cash and cash equivalents	(85,949)	45,314
Cash and cash equivalents at the beginning of the period	357,161	333,558
Cash and cash equivalents at the end of the period	271,212	378,872
Non cash financing activities of continuing operations:
Acquisition of treasury stock associated with settlement and exchange of convertible note hedge and warrant agreements	$ 0	$ 17,872

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2017		46,871				1,704
Beginning Balance at Dec. 31, 2017	$ 2,430,531	$ 46,871	$ 591,721	$ 2,285,886	$ (265,091)	$ (228,856)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	56,184			56,184
Cash dividends ($0.34 per share)	(15,447)			(15,447)
Other comprehensive (loss) income	82,690				82,690
Shares issued under compensation plans (in shares)		(97)				(43)
Shares issued under compensation plans	4,122	$ 97	992			$ 3,033
Deferred compensation (in shares)						(8)
Deferred compensation	322					$ 322
Settlements of note hedges associated with convertible notes	(12)		(17,884)			$ 17,872
Settlements of note hedges associated with convertible notes (in shares)						(132)
Ending Balance (in shares) at Apr. 01, 2018		46,968				1,521
Ending Balance at Apr. 01, 2018	2,560,500	$ 46,968	574,829	2,328,733	(182,401)	$ (207,629)
Beginning Balance (in shares) at Dec. 31, 2018		47,248				1,232
Beginning Balance at Dec. 31, 2018	2,539,978	$ 47,248	574,761	2,427,599	(341,085)	$ (168,545)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40,897			40,897
Cash dividends ($0.34 per share)	(15,650)			(15,650)
Other comprehensive (loss) income	396				396
Shares issued under compensation plans (in shares)		(75)				(40)
Shares issued under compensation plans	5,198	$ 75	$ 3,094			$ 2,029
Deferred compensation (in shares)			(127)			(4)
Deferred compensation	380					$ 253
Ending Balance (in shares) at Mar. 31, 2019		47,323				1,188
Ending Balance at Mar. 31, 2019	$ 2,569,878	$ 47,323	$ 577,982	$ 2,451,525	$ (340,689)	$ (166,263)

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical)	3 Months Ended
	Mar. 31, 2019$ / shares
Statement of Stockholders' Equity [Abstract]
Dividends per share (in dollars per share)	$ 0.34

Basis of presentation

Basis of presentation	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Note 1 — Basis of presentation The accompanying unaudited condensed consolidated financial statements of Teleflex Incorporated and its subsidiaries (“we,” “us,” “our,” “Teleflex” and the “Company”) are prepared on the same basis as its annual consolidated financial statements. In the opinion of management, the financial statements reflect all adjustments, which are of a normal recurring nature, necessary for the fair presentation of financial statements for interim periods in accordance with accounting principles generally accepted in the United States of America ("GAAP") and with Rule 10-01 of Securities and Exchange Commission ("SEC") Regulation S-X, which sets forth the instructions for financial statements included in Form 10-Q. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The results of operations for the periods reported are not necessarily indicative of those that may be expected for a full year. In accordance with applicable accounting standards and as permitted by Rule 10-01 of Regulation S-X, the accompanying condensed consolidated financial statements do not include all of the information and footnote disclosures that are required to be included in the Company's annual consolidated financial statements. Therefore, the Company's quarterly condensed consolidated financial statements should be read in conjunction with the Company's consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2018 .

Recently issued accounting stan

Recently issued accounting standards	3 Months Ended
	Mar. 31, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently issued accounting standards	accounting standards In February 2016, the FASB issued guidance that changes the requirements for accounting for leases. Under the new guidance, in connection with a lease as to which an entity is a lessee, the entity generally must recognize a right-to-use asset and a lease liability on the balance sheet, initially measured as the present value of lease payments under the lease. Under previous guidance, operating leases were not recognized on the balance sheet. The Company adopted the new standard on January 1, 2019 using a modified retrospective transition approach, which requires leases existing at, or entered into after, January 1, 2019 to be recognized and measured in the condensed consolidated balance sheet. The Company recognized additional net lease assets and lease liabilities of $105.3 million and $106.6 million , respectively, upon adoption of the guidance. The difference between the additional lease assets and lease liabilities was recorded as an adjustment to the Company's opening balance of retained earnings. Prior period amounts have not been adjusted and continue to reflect the Company's historical accounting. As permitted under the new guidance, the Company has made an accounting policy election not to apply the recognition provisions of the new guidance to short term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis over the lease term. In addition, the Company has elected to apply certain practical expedients available under the new guidance. As a result, and in connection with the transition to the new guidance, the Company will not reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, or (iii) initial direct costs for any existing leases. The Company applied the practical expedients described above to its entire lease portfolio at the January 1, 2019 adoption date. Furthermore, as permitted under the new guidance, the Company has made, as a practical expedient, an accounting policy election to not separate lease and non-lease components and instead will account for each separate lease component and the non-lease components associated with that lease component as a single lease component. Additional information and disclosures required by this standard are contained in Note 8. In February 2018, the FASB issued new guidance to address a narrow-scope financial reporting issue that arose as a consequence of federal tax legislation commonly referred to as the Tax Cuts and Jobs Act ("the TCJA"). Existing guidance requires that deferred tax liabilities and assets be adjusted for a change in tax laws or rates with the effect included in income from continuing operations in the reporting period that includes the enactment date. The guidance is applicable even in situations in which the related income tax effects of items in accumulated other comprehensive income were originally recognized in other comprehensive income (rather than in net income), such as amounts related to benefit plans and hedging activity. As a result, the tax effects of items within accumulated other comprehensive income (referred to as stranded tax effects) do not reflect the appropriate tax rate. The new guidance, which was effective January 1, 2019, permits reclassification of these amounts from accumulated other comprehensive income to retained earnings thereby eliminating the stranded tax effects. The new guidance also requires certain disclosures about the stranded tax effects. The Company elected not to reclassify stranded tax effects from accumulated other comprehensive income to retained earnings. From time to time, new accounting guidance is issued by the FASB or other standard setting bodies that is adopted by the Company as of the effective date or, in some cases where early adoption is permitted, in advance of the effective date. The Company has assessed the recently issued guidance that is not yet effective and, unless otherwise indicated above, believes the new guidance will not have a material impact on the its consolidated results of operations, cash flows or financial position.

Net revenues

Net revenues	3 Months Ended
	Mar. 31, 2019
Revenue from Contract with Customer [Abstract]
Net revenues	Net revenues The Company primarily generates revenue from the sale of medical devices including single use disposable devices and, to a lesser extent, reusable devices, instruments and capital equipment. Revenue is recognized when obligations under the terms of a contract with the Company’s customer are satisfied; this occurs upon the transfer of control of the products. Generally, transfer of control to the customer occurs at the point in time when the Company’s products are shipped from the manufacturing or distribution facility. For the Company’s Original Equipment and Development Services ("OEM") segment, most revenue is recognized over time because the OEM segment generates revenue from the sale of custom products that have no alternative use and the Company has an enforceable right to payment to the extent that performance has been completed. The Company markets and sells products through its direct sales force and distributors to customers within the following end markets: (1) hospitals and healthcare providers; (2) other medical device manufacturers; and (3) home care providers such as pharmacies, which comprised 87% , 10% and 3% of consolidated net revenues, respectively, for the three months ended March 31, 2019 . Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. With respect to the custom products sold in the OEM segment, revenue is measured using the units produced output method. Payment is generally due 30 days from the date of invoice. The following table disaggregates revenue by global product category for the three months ended March 31, 2019 and April 1, 2018 . Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) Vascular access $ 143,897 $ 144,028 Anesthesia 80,252 84,922 Interventional 103,184 90,142 Surgical 86,719 85,621 Interventional urology 59,731 42,300 OEM 54,238 45,854 Other (1) 85,563 94,363 Net revenues (2) $ 613,584 $ 587,230 (1) Revenues in the "Other" category in the table above include revenues generated from sales of the Company’s respiratory and urology products. For the three months ended March 31, 2019, the Company reclassified its cardiac products from "Other" to "Interventional". The comparative prior year period has been restated to conform to the current period presentation. (2) The product categories listed above are presented on a global basis; in contrast, the Company’s reportable segments are defined exclusively based on the geographic location of segment operations (with the exception of the OEM reportable segment, which operates globally). The Company’s geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.

Divestitures

Divestitures	3 Months Ended
	Mar. 31, 2019
Discontinued Operations and Disposal Groups [Abstract]
Divestitures	Divestitures On February 4, 2019, the Company sold substantially all the assets related to its vein catheter reprocessing business for $12.6 million . The Company recognized a $2.7 million pre-tax gain on the sale of assets, which represents the excess of the $9.7 million fair value of consideration received over the carrying value of the assets sold. In connection with the sale, the purchaser of the assets issued a secured promissory note to the Company in the principal amount of $10.5 million . The purchaser's obligations under the notes are secured by a lien on substantially all of the purchaser's assets. The purchaser is obligated to repay the principal amount of the promissory note in annual installments of $2.1 million over the next five years. On the closing date, the fair value of the promissory note was $7.6 million , which the Company calculated by applying a discount rate determined after taking into account the creditworthiness of the purchaser. As of March 31, 2019, the Company recorded $7.8 million as receivables in connection with the promissory note, of which $1.9 million and $5.9 million are included in accounts receivable, net and other assets, respectively, within the condensed consolidated balance sheet.

Restructuring charges and impai

Restructuring charges and impairment charges	3 Months Ended
	Mar. 31, 2019
Restructuring and Related Activities [Abstract]
Restructuring charges and impairment charges	Restructuring and impairment charges The following tables provide information regarding restructuring and impairment charges recognized by the Company for the three months ended March 31, 2019 and April 1, 2018 : Three Months Ended March 31, 2019 Termination benefits Other costs (1) Total (Dollars in thousands) 2019 Footprint realignment plan $ 12,975 $ — $ 12,975 2018 Footprint realignment plan $ 437 $ 574 $ 1,011 Other restructuring programs (2) 126 253 379 Restructuring charges $ 13,538 $ 827 $ 14,365 Asset impairment charges — 3,030 3,030 Restructuring and impairment charges $ 13,538 $ 3,857 $ 17,395 Three Months Ended April 1, 2018 Termination benefits Other costs (1) Total (Dollars in thousands) 2016 Footprint realignment plan (3) 1,955 194 2,149 2014 Footprint realignment plan 116 8 124 Other restructuring programs (4) 585 205 790 Restructuring charges $ 2,656 $ 407 $ 3,063 (1) Other costs include facility closure, contract termination and other exit costs. (2) Includes the Vascular Solutions integration program (initiated in 2017) as well as the 2016 and 2014 Footprint realignment plans. (3) The 2016 Footprint realignment plan involved the relocation of certain manufacturing operations, the relocation and outsourcing of certain distribution operations and a related workforce reduction at certain of the Company's facilities. The program is substantially complete and the Company expects future restructuring expenses associated with the program, if any, to be immaterial. (4) Includes the Vascular Solutions integration program and the EMEA restructuring program (both initiated in 2017). 2019 Footprint Realignment Plan In February 2019, the Company initiated a restructuring plan primarily involving the relocation of certain manufacturing operations to existing lower-cost locations and related workforce reductions (the "2019 Footprint realignment plan"). These actions are expected to be substantially completed during 2022. The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2019 Footprint realignment plan: Type of expense Total estimated amount expected to be incurred Termination benefits $19 million to $23 million Other exit costs (1) $1 million to $2 million Restructuring charges $20 million to $25 million Restructuring related charges (2) $36 million to $45 million Total restructuring and restructuring related charges $56 million to $70 million (1) Includes facility closure, employee relocation, equipment relocation and outplacement costs. (2) Restructuring related charges represent costs that are directly related to the 2019 Footprint realignment plan and principally constitute costs to transfer manufacturing operations to existing lower-cost locations, project management costs and accelerated depreciation. Most of these charges are expected to be recognized in cost of goods sold. In addition to the restructuring charges shown in the tables above, the Company recorded restructuring related charges with respect to the 2019 Footprint realignment plan of $0.6 million for the three months ended March 31, 2019 within cost of goods sold. As of March 31, 2019, the Company has a restructuring reserve of $12.5 million in connection with this plan, all of which relate to termination benefits. 2018 Footprint Realignment Plan On May 1, 2018, the Company initiated a restructuring plan involving the relocation of certain European manufacturing operations to existing lower-cost locations, the outsourcing of certain of the Company’s European distribution operations and related workforce reductions (the “2018 Footprint realignment plan"). These actions are expected to be substantially completed by the end of 2024. In addition to the restructuring charges shown in the tables above, the Company recorded restructuring related charges with respect to the 2018 Footprint realignment plan of $0.6 million for the three months ended March 31, 2019 , within cost of goods sold. The majority of these restructuring related charges in both periods constituted costs arising from the transfer of manufacturing operations to new locations. The Company estimates that is will incur aggregate pre-tax restructuring and restructuring related charges in connection with the 2018 Footprint realignment plan of approximately $102 million to $133 million . As of March 31, 2019 , the Company has incurred aggregate restructuring charges in connection with the 2018 Footprint realignment plan of $56.0 million . In addition, as of March 31, 2019 , the Company has incurred aggregate restructuring related charges of $4.7 million with respect to the 2018 Footprint realignment plan, consisting of accelerated depreciation and certain other costs that principally resulted from the transfer of manufacturing operations to new locations. The restructuring related charges primarily were included in cost of goods sold. As of March 31, 2019 , the Company has a restructuring reserve of $47.5 million in connection with this plan, all of which related to termination benefits. 2014 Footprint Realignment Plan In 2014, the Company initiated a restructuring plan (“the 2014 Footprint realignment plan”) involving the consolidation of operations and a related reduction in workforce at certain facilities, and the relocation of manufacturing operations from certain higher-cost locations to existing lower-cost locations. These actions commenced in the second quarter 2014 and are expected to be substantially completed by the end of 2020. The Company recorded restructuring related charges with respect to the 2014 Footprint realignment plan of $0.7 million and $0.4 million for the three months ended March 31, 2019 , and April 1, 2018 , respectively. The majority of these restructuring related charges in both periods constituted costs arising from the transfer of manufacturing operations to new locations. The Company estimates that it will incur aggregate pre-tax restructuring and restructuring related charges in connection with the 2014 Footprint realignment plan of $47 million to $52 million . As of March 31, 2019 , the Company has incurred aggregate restructuring charges of $12.7 million in connection with the 2014 Footprint realignment plan . Additionally, as of March 31, 2019 , the Company has incurred aggregate restructuring related charges of $29.8 million in connection with the 2014 Footprint realignment plan, consisting of accelerated depreciation and certain other costs that principally resulted from the transfer of manufacturing operations from the existing locations to new locations. These restructuring related charges primarily were included in cost of goods sold. As of March 31, 2019 , the Company has a restructuring reserve of $3.8 million in connection with the plan, all of which related to termination benefits. As the restructuring programs progress, management will reevaluate the estimated expenses and charges set forth above, and may revise its estimates, as appropriate, consistent with GAAP. For additional information related to the Company's restructuring programs, see Note 5 to the Company's consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2018.

Inventories, net

Inventories, net	3 Months Ended
	Mar. 31, 2019
Inventory Disclosure [Abstract]
Inventories, net	Inventories, net Inventories as of March 31, 2019 and December 31, 2018 consisted of the following: March 31, 2019 December 31, 2018 (Dollars in thousands) Raw materials $ 116,257 $ 111,105 Work-in-process 69,866 62,334 Finished goods 259,443 254,339 Inventories, net $ 445,566 $ 427,778

Goodwill and other intangible a

Goodwill and other intangible assets, net	3 Months Ended
	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and other intangible assets, net	Note 7 — Goodwill and other intangible assets, net The following table provides information relating to changes in the carrying amount of goodwill by reportable operating segment for the three months ended March 31, 2019 : Americas EMEA Asia OEM Total (Dollars in thousands) December 31, 2018 $ 1,549,534 $ 480,615 $ 211,547 $ 4,883 $ 2,246,579 Goodwill related to acquisitions 174 75 476 — 725 Currency translation adjustment 485 (1,460 ) — 1,439 — 464 March 31, 2019 $ 1,550,193 $ 479,230 $ 213,462 $ 4,883 $ 2,247,768 The Company's gross carrying amount of, and accumulated amortization relating to, intangible assets as of March 31, 2019 and December 31, 2018 were as follows: Gross Carrying Amount Accumulated Amortization March 31, 2019 December 31, 2018 March 31, 2019 December 31, 2018 (Dollars in thousands) Customer relationships $ 1,022,131 $ 1,030,194 $ (333,633 ) $ (322,972 ) In-process research and development 28,137 28,457 — — Intellectual property 1,358,049 1,363,516 (341,986 ) (322,539 ) Distribution rights 23,405 23,465 (18,075 ) (17,860 ) Trade names 564,045 565,070 (39,904 ) (36,379 ) Non-compete agreements 22,840 23,004 (10,521 ) (8,904 ) $ 3,018,607 $ 3,033,706 $ (744,119 ) $ (708,654 )

Leases (Notes)

Leases (Notes)	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Leases	Leases The Company has operating leases for various types of properties, consisting of manufacturing plants, engineering and research centers, distribution warehouses, offices and other facilities, and equipment used in operations. Some leases provide the Company with an option, exercisable at the Company's sole discretion, to terminate the lease or extend the lease term for one or more years. When measuring assets and liabilities arising from a lease that provides the Company with an option to extend the lease term, the Company takes into account payments to be made in the optional extension period when it is reasonably certain that the Company will exercise the option. Total lease cost (all of which related to operating leases) was $6.1 million for the three months ended March 31, 2019 . Maturities of lease liabilities March 31, 2019 (Dollars in thousands) 2019 $ 18,674 2020 24,274 2021 21,931 2022 19,739 2023 16,137 2024 and thereafter 40,682 Total lease payments 141,437 Less: interest (20,384 ) Present value of lease liabilities 121,053 Supplemental information March 31, 2019 (Dollars in thousands) Total lease liabilities (1) $ 121,053 Cash paid for amounts included in the measurement of lease liabilities within operating cash flows $ 6,900 Right of use assets obtained in exchange for operating lease obligations $ 17,519 Weighted average remaining lease term 6.79 years Weighted average discount rate 4.23 % (1) The current portion of the operating lease liabilities of $20.3 million is included in Other current liabilities. As of December 31, 2018 , minimum lease payments under noncancellable operating leases were expected to be as follows: December 31, 2018 (Dollars in thousands) 2019 $ 25,294 2020 23,216 2021 21,419 2022 19,460 2023 17,403 2024 and thereafter 41,368

Financial instruments

Financial instruments	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial instruments	Financial instruments Foreign currency forward contracts The Company uses derivative instruments for risk management purposes. Foreign currency forward contracts designated as cash flow hedges are used to manage exposure related to foreign currency transactions. Foreign currency forward contracts not designated as hedges for accounting purposes are used to manage exposure related to near term foreign currency denominated monetary assets and liabilities. The Company enters into the non-designated foreign currency forward contracts for periods consistent with its currency translation exposures, which generally approximate one month. For the three months ended March 31, 2019 , the Company recognized a loss related to non-designated foreign currency forward contracts of $3.0 million . For the three months ended April 1, 2018 , the Company recognized a gain related to non-designated foreign currency forward contracts of $0.6 million . The total notional amount for all open foreign currency forward contracts designated as cash flow hedges as of March 31, 2019 and December 31, 2018 was $63.4 million and $115.3 million , respectively. The total notional amount for all open non-designated foreign currency forward contracts as of March 31, 2019 and December 31, 2018 was $132.8 million and $125.9 million , respectively. All open foreign currency forward contracts as of March 31, 2019 have durations of twelve months or less. Cross-currency interest rate swaps On March 4, 2019, the Company entered into cross-currency swap agreements with five different financial institution counterparties to hedge against the effect of variability in the U.S. dollar to euro exchange rate. Under the terms of the cross-currency swap agreements, the Company has notionally exchanged $250 million at an annual interest rate of 4.8750% for €219.2 million at an annual interest rate of 2.4595% . The swap agreements are designed as net investment hedges and expire on March 4, 2024. On October 4, 2018, the Company entered into cross-currency swap agreements with six different financial institution counterparties to hedge against the effect of variability in the U.S. dollar to euro exchange rate. Under the terms of the cross-currency swap agreements, the Company has notionally exchanged $500 million at an annual interest rate of 4.625% for €433.9 million at an annual interest rate of 1.942% . The swap agreements are designed as net investment hedges and expire on October 4, 2023. The swap agreements described above require an exchange of the notional amounts upon expiration or earlier termination of the agreements. We and the counterparties have agreed to effect the exchange through a net settlement. The cross-currency swaps are marked to market at each reporting date and any changes in fair value are recognized as a component of Accumulated other comprehensive income (loss) ("AOCI"). For the three months ended March 31, 2019 , the Company recognized foreign exchange gain of $10.6 million in foreign currency translation adjustments within AOCI related to the cross-currency swaps. Balance Sheet Presentation The following table presents the locations in the condensed consolidated balance sheet and fair value of derivative financial instruments as of March 31, 2019 and December 31, 2018 : March 31, 2019 December 31, 2018 Fair Value (Dollars in thousands) Asset derivatives: Designated foreign currency forward contracts $ 883 $ 1,216 Non-designated foreign currency forward contracts 264 106 Cross-currency interest rate swap 23,129 14,728 Prepaid expenses and other current assets 24,276 16,050 Cross-currency interest rate swap 11 — Other assets 11 — Total asset derivatives 24,287 16,050 Liability derivatives: Designated foreign currency forward contracts 1,054 524 Non-designated foreign currency forward contracts 533 264 Other current liabilities 1,587 788 Cross-currency interest rate swap 3,713 7,793 Other liabilities 3,713 7,793 Total liability derivatives $ 5,300 $ 8,581 See Note 11 for information on the location and amount of gains and losses attributable to derivatives that were reclassified from AOCI to expense (income), net of tax. There was no ineffectiveness related to the Company’s cash flow hedges during the three months ended March 31, 2019 and April 1, 2018 .

Fair value measurement

Fair value measurement	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Fair value measurement	Fair value measurement For a description of the fair value hierarchy, see Note 11 to the Company’s consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2018 . The following tables provide information regarding the Company's financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018 : Total carrying Quoted prices in active Significant other Significant (Dollars in thousands) Investments in marketable securities $ 9,690 $ 9,690 $ — $ — Derivative assets 24,287 — 24,287 — Derivative liabilities 5,300 — 5,300 — Contingent consideration liabilities 180,362 — — 180,362 Total carrying Quoted prices in active Significant other Significant (Dollars in thousands) Investments in marketable securities $ 8,671 $ 8,671 $ — $ — Derivative assets 16,050 — 16,050 — Derivative liabilities 8,581 — 8,581 — Contingent consideration liabilities 304,248 — — 304,248 There were no transfers of financial assets or liabilities reported at fair value among Level 1, Level 2 or Level 3 within the fair value hierarchy during the three months ended March 31, 2019 . Valuation Techniques The Company’s financial assets valued based upon Level 1 inputs are comprised of investments in marketable securities held in trust, which are available to satisfy benefit obligations under Company benefit plans and other arrangements. The investment assets of the trust are valued using quoted market prices. The Company’s financial assets and liabilities valued based upon Level 2 inputs are comprised of foreign currency forward contracts and cross-currency interest rate swap agreements. The Company uses foreign currency forward contracts and cross-currency interest rate swap agreements to manage foreign currency transaction exposure as well as exposure to foreign currency denominated monetary assets and liabilities. The Company measures the fair value of the foreign currency forward and cross-currency swap agreements by calculating the amount required to enter into offsetting contracts with similar remaining maturities, based on quoted market prices, and taking into account the creditworthiness of the counterparties. The Company’s financial liabilities valued based upon Level 3 inputs (inputs that are not observable in the market) are comprised of contingent consideration arrangements pertaining to the Company’s acquisitions, which are discussed immediately below. Contingent consideration Contingent consideration liabilities, which primarily consist of revenue-based goals, are remeasured to fair value each reporting period using assumptions including estimated revenues (based on internal operational budgets and long-range strategic plans), discount rates, probability of payment and projected payment dates. The Company determines the fair value of the contingent consideration liabilities using a Monte Carlo simulation (which involves a simulation of future revenues during the earn out-period using management's best estimates) or a probability-weighted discounted cash flow analysis. Increases in projected revenues, estimated cash flows and probabilities of payment may result in significantly higher fair value measurements; decreases in these items may have the opposite effect. Increases in the discount rates in periods prior to payment may result in significantly lower fair value measurements and decreases in the discount rates may have the opposite effect. The table below provides additional information regarding the valuation technique and inputs used in determining the fair value of contingent consideration. Contingent Consideration Liability Valuation Technique Unobservable Input Range Milestone-based payment Discounted cash flow Discount rate 4.1% - 5.7% Projected year of payment 2019 - 2023 Revenue-based Monte Carlo simulation Revenue volatility 19.7% - 24.7% Risk free rate Cost of debt structure Projected year of payment 2020 - 2022 Discounted cash flow Discount rate 10.0% - 10.5% Projected year of payment 2019 - 2029 The following table provides information regarding changes in the Company's contingent consideration liabilities during the three months ended March 31, 2019 : Contingent consideration 2019 (Dollars in thousands) Balance - December 31, 2018 $ 304,248 Payments (1) (136,888 ) Revaluations 13,057 Translation adjustment (55 ) Balance - March 31, 2019 $ 180,362 (1) Consists mainly of a $106.8 million payment associated with the Company's acquisition of NeoTract, Inc. and resulting from the achievement of a sales goal for the period from January 1, 2018 to December 31, 2018 and $30.0 million of payments associated with the Company's acquisition of Essential Medical, Inc. and resulting from achievement of a regulatory goal.

Shareholders' equity

Shareholders' equity	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Shareholders' equity	Shareholders’ equity Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner except that the weighted average number of shares is increased to include dilutive securities. The following table provides a reconciliation of basic to diluted weighted average number of common shares outstanding: Three Months Ended March 31, 2019 April 1, 2018 (Shares in thousands) Basic 46,050 45,329 Dilutive effect of share-based awards 892 1,044 Dilutive effect of convertible warrants — 322 Diluted 46,942 46,695 The weighted average number of shares that were antidilutive and therefore excluded from the calculation of earnings per share were 0.1 million and 0.6 million for the three months ended March 31, 2019 and April 1, 2018 , respectively. The following tables provide information relating to the changes in accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019 and April 1, 2018 : Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2018 $ 807 $ (131,380 ) $ (210,512 ) $ (341,085 ) Other comprehensive income (loss) before reclassifications (434 ) (122 ) (236 ) (792 ) Amounts reclassified from accumulated other comprehensive income (163 ) 1,351 — 1,188 Net current-period other comprehensive income (loss) (597 ) 1,229 (236 ) 396 Balance as of March 31, 2019 $ 210 $ (130,151 ) $ (210,748 ) $ (340,689 ) Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2017 $ 340 $ (138,808 ) $ (126,623 ) $ (265,091 ) Other comprehensive (loss) before reclassifications 1,341 (478 ) 81,188 82,051 Amounts reclassified from accumulated other comprehensive loss (720 ) 1,359 — 639 Net current-period other comprehensive income 621 881 81,188 82,690 Balance as of April 1, 2018 $ 961 $ (137,927 ) $ (45,435 ) $ (182,401 ) The following table provides information relating to the location in the statements of operations and amount of reclassifications of losses/(gains) in accumulated other comprehensive (loss) income into expense/(income), net of tax, for the three months ended March 31, 2019 and April 1, 2018 : Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) (Gains) losses on foreign exchange contracts: Cost of goods sold $ (186 ) $ (833 ) Total before tax (186 ) (833 ) Taxes (benefit) 23 113 Net of tax $ (163 ) $ (720 ) Losses (gains) on cross-currency swaps (net investment hedge): Interest expense $ (3,882 ) $ — Total before tax (3,882 ) — Tax expense 929 — Net of tax $ (2,953 ) $ — Amortization of pension and other postretirement benefit items (1): Actuarial losses $ 1,740 $ 1,746 Prior-service costs 22 24 Total before tax 1,762 1,770 Tax benefit (411 ) (411 ) Net of tax $ 1,351 $ 1,359 Total reclassifications, net of tax $ (1,765 ) $ 639 (1) These accumulated other comprehensive (loss) income components are included in the computation of net benefit expense for pension and other postretirement benefit plans.

Taxes on income from continuing

Taxes on income from continuing operations	3 Months Ended
	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Taxes on income from continuing operations	Taxes on income from continuing operations Three Months Ended March 31, 2019 April 1, 2018 Effective income tax rate 20.7% 10.2% The effective income tax rate for the three months ended March 31, 2019 and April 1, 2018 was 20.7% and 10.2% , respectively. The effective income tax rate for the three months ended March 31, 2019 , as compared to the prior year period, reflects the impact of non-deductible termination benefits incurred in connection with the 2019 Footprint realignment plan. In addition, the effective tax rate for the three months ended March 31, 2019 and April 1, 2018 include the benefit of a lower U.S. corporate income tax rate of 21.0% resulting from the enactment of the TCJA, partially offset by tax costs associated with the global intangible low income provisions of the TCJA, which require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary's intangible assets, and other TCJA-related changes.

Commitments and contingent liab

Commitments and contingent liabilities	3 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingent liabilities	Commitments and contingent liabilities Environmental: The Company is subject to contingencies as a result of environmental laws and regulations that in the future may require the Company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the Company or other parties. Much of this liability results from the U.S. Comprehensive Environmental Response, Compensation and Liability Act, often referred to as Superfund, the U.S. Resource Conservation and Recovery Act and similar state laws. These laws require the Company to undertake certain investigative and remedial activities at sites where the Company conducts or once conducted operations or at sites where Company-generated waste was disposed. Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, the regulatory agencies involved and their enforcement policies, as well as the presence or absence of other potentially responsible parties. At March 31, 2019 , the Company has recorded $0.9 million and $6.6 million in accrued liabilities and other liabilities, respectively, relating to these matters. Considerable uncertainty exists with respect to these liabilities and, if adverse changes in circumstances occur, the potential liability may exceed the amount accrued as of March 31, 2019 . The time frame over which the accrued amounts may be paid out, based on past history, is estimated to be 10 - 15 years. Litigation: The Company is a party to various lawsuits and claims arising in the normal course of business. These lawsuits and claims include actions involving product liability, product warranty, commercial disputes, intellectual property, contract, employment, environmental and other matters. As of March 31, 2019 , the Company has recorded accrued liabilities of $0.4 million in connection with such contingencies, representing its best estimate of the cost within the range of estimated possible losses that will be incurred to resolve these matters. Based on information currently available, advice of counsel, established reserves and other resources, the Company does not believe that the outcome of any outstanding litigation and claims is likely to be, individually or in the aggregate, material to its business, financial condition, results of operations or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company’s business, financial condition, results of operations or liquidity. Legal costs such as outside counsel fees and expenses are charged to selling, general and administrative expenses in the period incurred. Tax audits and examinations: The Company and its subsidiaries are routinely subject to tax examinations by various tax authorities. As of March 31, 2019 , the most significant tax examination in process is in Germany. The Company may establish reserves with respect to its uncertain tax positions, after which it adjusts the reserves to address developments with respect to its uncertain tax positions, including developments in this tax examination. Accordingly, developments in tax audits and examinations, including resolution of uncertain tax positions, could result in increases or decreases to the Company’s recorded tax liabilities, which could impact the Company’s financial results. Other: The Company has various purchase commitments for materials, supplies and other items occurring in the ordinary conduct of its business. On average, such commitments are not at prices in excess of current market prices.

Segment information

Segment information	3 Months Ended
	Mar. 31, 2019
Segment Reporting [Abstract]
Segment information	Segment information During the first quarter 2019, the chief operating decision maker, or CODM, (the Company's Chief Executive Officer) changed the manner in which he reviews financial information for purposes of assessing business performance and allocating resources by focusing on the geographic location of all non-OEM operations. As a result, the Company changed its segment presentation. Specifically, the Vascular North America, Interventional North America, Anesthesia North America, Surgical North America, Interventional Urology North America, Respiratory North America and Latin America operating segments were combined into a new Americas segment. The Company now has four segments: Americas, EMEA, Asia and OEM. All prior comparative periods presented have been restated to reflect these changes. The following tables present the Company’s segment results for the three months ended March 31, 2019 and April 1, 2018 : Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) Americas $ 344,024 $ 323,262 EMEA 154,545 159,870 Asia 60,777 58,244 OEM 54,238 45,854 Net revenues $ 613,584 $ 587,230 Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) Americas $ 65,599 $ 58,890 EMEA 27,023 31,770 Asia 9,979 13,368 OEM 13,321 9,016 Total segment operating profit (1) 115,922 113,044 Unallocated expenses (2) (40,679 ) (26,201 ) Income from continuing operations before interest and taxes $ 75,243 $ 86,843 (1) Segment operating profit includes segment net revenues from external customers reduced by the segment's standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as net revenues, numbers of employees, and amount of time spent), depending on the category of expense involved. (2) Unallocated expenses primarily include manufacturing variances other than fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.

Condensed consolidating guarant

Condensed consolidating guarantor financial information	3 Months Ended
	Mar. 31, 2019
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed consolidating guarantor financial information	Condensed consolidating guarantor financial information The 2024 Notes, 2026 Notes and 2027 Notes (collectively, the "Senior Notes") are issued by Teleflex Incorporated (the “Parent Company”), and payment of the Parent Company's obligations under the Senior Notes are guaranteed, jointly and severally, by certain of the Parent Company’s subsidiaries (each, a “Guarantor Subsidiary” and collectively, the “Guarantor Subsidiaries”). The 2024 Notes, 2026 Notes and 2027 Notes are guaranteed by the same Guarantor Subsidiaries. The guarantees are full and unconditional, subject to certain customary release provisions. Each Guarantor Subsidiary is directly or indirectly 100% owned by the Parent Company. The Company’s condensed consolidating statements of income and comprehensive income for the three months ended March 31, 2019 and April 1, 2018 , condensed consolidating balance sheets as of March 31, 2019 and December 31, 2018 and condensed consolidating statements of cash flows for the three months ended March 31, 2019 and April 1, 2018 , provide consolidated information for: a. Parent Company, the issuer of the guaranteed obligations; b. Guarantor Subsidiaries, on a combined basis; c. Non-Guarantor Subsidiaries (i.e., those subsidiaries of the Parent Company that have not guaranteed payment of the Senior Notes), on a combined basis; and d. Parent Company and its subsidiaries on a consolidated basis. The same accounting policies as described in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 are used by the Parent Company and each of its subsidiaries in connection with the condensed consolidating financial information, except for the use of the equity method of accounting to reflect ownership interests in subsidiaries, which are eliminated upon consolidation. Consolidating entries and eliminations in the following condensed consolidated financial statements represent adjustments to (a) eliminate intercompany transactions between or among the Parent Company, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries, (b) eliminate the investments in subsidiaries and (c) record consolidating entries. TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME Three Months Ended March 31, 2019 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 415,143 $ 320,993 $ (122,552 ) $ 613,584 Cost of goods sold — 234,217 147,857 (113,232 ) 268,842 Gross profit — 180,926 173,136 (9,320 ) 344,742 Selling, general and administrative expenses 16,167 131,702 79,466 358 227,693 Research and development expenses 484 20,121 6,545 — 27,150 Restructuring and impairment charges — 5,973 11,422 — 17,395 Gain on sale of assets — — (2,739 ) — (2,739 ) (Loss) income from continuing operations before interest and taxes (16,651 ) 23,130 78,442 (9,678 ) 75,243 Interest, net 4,065 18,597 (309 ) — 22,353 (Loss) income from continuing operations before taxes (20,716 ) 4,533 78,751 (9,678 ) 52,890 (Benefit) taxes on (loss) income from continuing operations (8,872 ) 6,892 14,387 (1,435 ) 10,972 Equity in net income of consolidated subsidiaries 53,762 59,631 — (113,393 ) — Income from continuing operations 41,918 57,272 64,364 (121,636 ) 41,918 Operating loss from discontinued operations (1,343 ) — — — (1,343 ) Tax benefit on loss from discontinued operations (322 ) — — — (322 ) Loss from discontinued operations (1,021 ) — — — (1,021 ) Net income 40,897 57,272 64,364 (121,636 ) 40,897 Other comprehensive income 396 (1,501 ) (4,994 ) 6,495 396 Comprehensive income $ 41,293 $ 55,771 $ 59,370 $ (115,141 ) $ 41,293 Three Months Ended April 1, 2018 Parent Guarantor Non-Guarantor Eliminations Condensed Consolidated (Dollars in thousands) Net revenues $ — $ 379,419 $ 320,009 $ (112,198 ) $ 587,230 Cost of goods sold — 217,604 142,008 (103,652 ) 255,960 Gross profit — 161,815 178,001 (8,546 ) 331,270 Selling, general and administrative expenses 9,181 130,914 75,771 (529 ) 215,337 Research and development expenses 227 19,368 6,432 — 26,027 Restructuring charges — 908 2,155 — 3,063 (Loss) income from continuing operations before interest and taxes (9,408 ) 10,625 93,643 (8,017 ) 86,843 Interest, net 22,141 2,931 598 — 25,670 (Loss) income from continuing operations before taxes (31,549 ) 7,694 93,045 (8,017 ) 61,173 (Benefit) taxes on (loss) income from continuing operations (13,192 ) 6,423 14,177 (1,166 ) 6,242 Equity in net income of consolidated subsidiaries 74,567 76,876 293 (151,736 ) — Income from continuing operations 56,210 78,147 79,161 (158,587 ) 54,931 Operating (loss) income from discontinued operations (44 ) — 1,279 — 1,235 Tax benefit on loss from discontinued operations (18 ) — — — (18 ) (Loss) income from discontinued operations (26 ) — 1,279 — 1,253 Net income 56,184 78,147 80,440 (158,587 ) 56,184 Other comprehensive income 82,690 70,119 87,227 (157,346 ) 82,690 Comprehensive income $ 138,874 $ 148,266 $ 167,667 $ (315,933 ) $ 138,874 TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS March 31, 2019 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 39,022 $ 622 $ 231,568 $ — $ 271,212 Accounts receivable, net 4,286 62,457 304,037 4,976 375,756 Accounts receivable from consolidated subsidiaries 35,052 228,267 388,737 (652,056 ) — Inventories, net — 274,038 211,781 (40,253 ) 445,566 Prepaid expenses and other current assets 38,633 10,243 26,606 4,113 79,595 Prepaid taxes 4,631 — 5,854 — 10,485 Total current assets 121,624 575,627 1,168,583 (683,220 ) 1,182,614 Property, plant and equipment, net 3,167 230,983 175,813 — 409,963 Operating lease assets 14,679 62,027 35,572 — 112,278 Goodwill — 1,255,350 992,418 — 2,247,768 Intangibles assets, net 85 1,255,965 1,018,438 — 2,274,488 Investments in affiliates 6,043,371 1,771,617 — (7,814,988 ) — Deferred tax assets — — 4,885 (2,385 ) 2,500 Notes receivable and other amounts due from consolidated subsidiaries 1,976,376 2,722,166 284,413 (4,982,955 ) — Other assets 16,956 11,593 9,909 — 38,458 Total assets $ 8,176,258 $ 7,885,328 $ 3,690,031 $ (13,483,548 ) $ 6,268,069 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 36,625 $ — $ 50,000 $ — $ 86,625 Accounts payable 3,446 61,327 38,759 — 103,532 Accounts payable to consolidated subsidiaries 235,100 315,782 101,174 (652,056 ) — Accrued expenses 8,034 34,673 50,942 — 93,649 Current portion of contingent consideration — 98,622 1,064 — 99,686 Payroll and benefit-related liabilities 14,092 19,557 42,612 — 76,261 Accrued interest 23,200 — 45 — 23,245 Income taxes payable — — 8,076 (1,435 ) 6,641 Other current liabilities 4,414 14,425 12,438 — 31,277 Total current liabilities 324,911 544,386 305,110 (653,491 ) 520,916 Long-term borrowings 2,072,939 — — — 2,072,939 Deferred tax liabilities 90,195 258,470 264,326 (2,385 ) 610,606 Pension and postretirement benefit liabilities 46,154 27,162 15,971 — 89,287 Noncurrent liability for uncertain tax positions 912 7,267 2,654 — 10,833 Notes payable and other amounts due to consolidated subsidiaries 2,920,820 1,879,068 183,067 (4,982,955 ) — Noncurrent contingent consideration — 42,717 37,959 — 80,676 Noncurrent operating lease liabilities 12,218 61,390 27,100 — 100,708 Other liabilities 138,231 9,497 64,498 — 212,226 Total liabilities 5,606,380 2,829,957 900,685 (5,638,831 ) 3,698,191 Total shareholders' equity 2,569,878 5,055,371 2,789,346 (7,844,717 ) 2,569,878 Total liabilities and shareholders' equity $ 8,176,258 $ 7,885,328 $ 3,690,031 $ (13,483,548 ) $ 6,268,069 December 31, 2018 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 49,523 $ 1,757 $ 305,881 $ — $ 357,161 Accounts receivable, net 5,885 54,013 301,054 5,334 366,286 Accounts receivable from consolidated subsidiaries 32,036 1,043,573 350,162 (1,425,771 ) — Inventories, net — 266,073 192,659 (30,954 ) 427,778 Prepaid expenses and other current assets 30,458 9,673 28,237 4,113 72,481 Prepaid taxes 7,029 — 5,434 — 12,463 Total current assets 124,931 1,375,089 1,183,427 (1,447,278 ) 1,236,169 Property, plant and equipment, net 3,385 253,037 176,344 — 432,766 Goodwill — 1,254,848 991,731 — 2,246,579 Intangibles assets, net 90 1,277,462 1,047,500 — 2,325,052 Investments in affiliates 5,984,566 1,672,908 20,257 (7,677,731 ) — Deferred tax assets — — 4,822 (2,376 ) 2,446 Notes receivable and other amounts due from consolidated subsidiaries 2,337,737 2,523,156 13,242 (4,874,135 ) — Other assets 17,180 5,776 12,023 — 34,979 Total assets $ 8,467,889 $ 8,362,276 $ 3,449,346 $ (14,001,520 ) $ 6,277,991 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 36,625 $ — $ 50,000 $ — $ 86,625 Accounts payable 3,448 62,764 40,497 — 106,709 Accounts payable to consolidated subsidiaries 1,058,008 278,715 89,048 (1,425,771 ) — Accrued expenses 5,659 41,883 50,009 — 97,551 Current portion of contingent consideration — 106,514 30,363 — 136,877 Payroll and benefit-related liabilities 17,156 44,982 42,532 — 104,670 Accrued interest 5,995 — 36 — 6,031 Income taxes payable — — 5,943 — 5,943 Other current liabilities 843 34,916 2,291 — 38,050 Total current liabilities 1,127,734 569,774 310,719 (1,425,771 ) 582,456 Long-term borrowings 2,072,200 — — — 2,072,200 Deferred tax liabilities 87,671 257,522 265,404 (2,376 ) 608,221 Pension and postretirement benefit liabilities 49,290 27,454 16,170 — 92,914 Noncurrent liability for uncertain tax positions 801 7,212 2,705 — 10,718 Notes payable and other amounts due to consolidated subsidiaries 2,451,784 2,222,580 199,771 (4,874,135 ) — Noncurrent contingent consideration — 131,563 35,807 — 167,370 Other liabilities 138,431 8,204 57,499 204,134 Total liabilities 5,927,911 3,224,309 888,075 (6,302,282 ) 3,738,013 Total shareholders' equity 2,539,978 5,137,967 2,561,271 (7,699,238 ) 2,539,978 Total liabilities and shareholders' equity $ 8,467,889 $ 8,362,276 $ 3,449,346 $ (14,001,520 ) $ 6,277,991 TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended March 31, 2019 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (417 ) $ 57,823 $ 95,215 $ (92,455 ) $ 60,166 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (222 ) (17,784 ) (5,488 ) — (23,494 ) Proceeds from sale of assets and investments 2,362 991 — (2,362 ) 991 Payments for businesses and intangibles acquired, net of cash acquired — (1,025 ) — — (1,025 ) Net cash provided by (used in) investing activities from continuing operations 2,140 (17,818 ) (5,488 ) (2,362 ) (23,528 ) Cash flows from financing activities of continuing operations: Net proceeds from share based compensation plans and the related tax impacts 2,242 — — — 2,242 Payments for contingent consideration — (81,977 ) (28,976 ) — (110,953 ) Dividends paid (15,650 ) — — — (15,650 ) Intercompany transactions (2,426 ) 40,837 (40,773 ) 2,362 — Intercompany dividends paid — — (92,455 ) 92,455 — Net cash (used in) provided by financing activities from continuing operations (15,834 ) (41,140 ) (162,204 ) 94,817 (124,361 ) Cash flows from discontinued operations: Net cash provided by operating activities 3,610 — — — 3,610 Net cash provided by discontinued operations 3,610 — — — 3,610 Effect of exchange rate changes on cash and cash equivalents — — (1,836 ) — (1,836 ) Net decrease in cash and cash equivalents (10,501 ) (1,135 ) (74,313 ) — (85,949 ) Cash and cash equivalents at the beginning of the period 49,523 1,757 305,881 — 357,161 Cash and cash equivalents at the end of the period $ 39,022 $ 622 $ 231,568 $ — $ 271,212 Three Months Ended April 1, 2018 Parent Guarantor Non-Guarantor Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (108,377 ) $ 134,198 $ 61,027 $ 86,848 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (159 ) (5,015 ) (10,573 ) (15,747 ) Payments for businesses and intangibles acquired, net of cash acquired — — (3,684 ) (3,684 ) Net cash used in investing activities from continuing operations (159 ) (5,015 ) (14,257 ) (19,431 ) Cash flows from financing activities of continuing operations: Reduction in borrowings (18,500 ) — — (18,500 ) Debt extinguishment, issuance and amendment fees (74 ) — — (74 ) Net proceeds from share based compensation plans and the related tax impacts 1,400 — — 1,400 Payments for contingent consideration — (91 ) — (91 ) Dividends paid (15,447 ) — — (15,447 ) Intercompany transactions 131,967 (127,825 ) (4,142 ) — Net cash provided by (used in) financing activities from continuing operations 99,346 (127,916 ) (4,142 ) (32,712 ) Cash flows from discontinued operations: Net cash used in operating activities (206 ) — — (206 ) Net cash used in discontinued operations (206 ) — — (206 ) Effect of exchange rate changes on cash and cash equivalents — — 10,815 10,815 Net (decrease) increase in cash and cash equivalents (9,396 ) 1,267 53,443 45,314 Cash and cash equivalents at the beginning of the period 37,803 8,933 286,822 333,558 Cash and cash equivalents at the end of the period $ 28,407 $ 10,200 $ 340,265 $ 378,872

Subsequent event

Subsequent event	3 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
Subsequent event	Subsequent event On April 5, 2019, the Company amended and restated its existing credit agreement by entering into a Second Amended and Restated Credit Agreement (the "Credit Agreement"), which provides for a five -year revolving credit facility of $1.0 billion and a term loan facility of $700.0 million . The Company's obligations under the Credit Agreement are guaranteed (subject to certain exceptions and limitations) by substantially all of the material domestic subsidiaries of the Company. The obligations under the Credit Agreement are secured, subject to certain exceptions and limitations, by a lien on substantially all of the assets owned by the Company and each guarantor. The maturity date of the revolving credit facility and the term loan facility under the Credit Agreement is April 5, 2024. At the Company’s option, loans under the Credit Agreement will bear interest at a rate equal to adjusted LIBOR plus an applicable margin ranging from 1.125% to 2.00% or at an alternate base rate, which is defined as the highest of (i) the “Prime Rate” in the U.S. last quoted by The Wall Street Journal, (ii) 0.50% above the greater of the federal funds rate and the rate comprised of both overnight federal funds and overnight eurodollar borrowings and (iii) 1.00% above adjusted LIBOR for a one month interest period on such day, plus an applicable margin ranging from 0.125% to 1.00% , in each case subject to adjustments based on the Company’s consolidated total net leverage ratio. Overdue loans will bear interest at the rate otherwise applicable to such loans plus 2.00% . The Credit Agreement contains customary representations and warranties and covenants that, in each case, subject to certain exceptions, qualifications and thresholds, (a) place limitations on the Company and its subsidiaries regarding the incurrence of additional indebtedness, additional liens, fundamental changes, dispositions of property, investments and acquisitions, dividends and other restricted payments, transactions with affiliates, restrictive agreements, changes in lines of business and swap agreements, and (b) require the Company and its subsidiaries to comply with sanction laws and other laws and agreements, to deliver financial information and certain other information and give notice of certain events, to maintain their existence and good standing, to pay their other obligations, to permit the administrative agent and the lenders to inspect their books and property, to use the proceeds of the Credit Agreement only for certain permitted purposes and to provide collateral in the future. Subject to certain exceptions, the Company is required to maintain a maximum consolidated total net leverage ratio of 4.50 to 1.00. The Company is further required to maintain a minimum consolidated interest coverage ratio of 3.50 to 1.00.

Recently issued accounting st_2

Recently issued accounting standards (Policies)	3 Months Ended
	Mar. 31, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently issued accounting standards	Recently issued accounting standards In February 2016, the FASB issued guidance that changes the requirements for accounting for leases. Under the new guidance, in connection with a lease as to which an entity is a lessee, the entity generally must recognize a right-to-use asset and a lease liability on the balance sheet, initially measured as the present value of lease payments under the lease. Under previous guidance, operating leases were not recognized on the balance sheet. The Company adopted the new standard on January 1, 2019 using a modified retrospective transition approach, which requires leases existing at, or entered into after, January 1, 2019 to be recognized and measured in the condensed consolidated balance sheet. The Company recognized additional net lease assets and lease liabilities of $105.3 million and $106.6 million , respectively, upon adoption of the guidance. The difference between the additional lease assets and lease liabilities was recorded as an adjustment to the Company's opening balance of retained earnings. Prior period amounts have not been adjusted and continue to reflect the Company's historical accounting. As permitted under the new guidance, the Company has made an accounting policy election not to apply the recognition provisions of the new guidance to short term leases (leases with a lease term of 12 months or less that do not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise); instead, the Company will recognize the lease payments for short term leases on a straight-line basis over the lease term. In addition, the Company has elected to apply certain practical expedients available under the new guidance. As a result, and in connection with the transition to the new guidance, the Company will not reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, or (iii) initial direct costs for any existing leases. The Company applied the practical expedients described above to its entire lease portfolio at the January 1, 2019 adoption date. Furthermore, as permitted under the new guidance, the Company has made, as a practical expedient, an accounting policy election to not separate lease and non-lease components and instead will account for each separate lease component and the non-lease components associated with that lease component as a single lease component. Additional information and disclosures required by this standard are contained in Note 8. In February 2018, the FASB issued new guidance to address a narrow-scope financial reporting issue that arose as a consequence of federal tax legislation commonly referred to as the Tax Cuts and Jobs Act ("the TCJA"). Existing guidance requires that deferred tax liabilities and assets be adjusted for a change in tax laws or rates with the effect included in income from continuing operations in the reporting period that includes the enactment date. The guidance is applicable even in situations in which the related income tax effects of items in accumulated other comprehensive income were originally recognized in other comprehensive income (rather than in net income), such as amounts related to benefit plans and hedging activity. As a result, the tax effects of items within accumulated other comprehensive income (referred to as stranded tax effects) do not reflect the appropriate tax rate. The new guidance, which was effective January 1, 2019, permits reclassification of these amounts from accumulated other comprehensive income to retained earnings thereby eliminating the stranded tax effects. The new guidance also requires certain disclosures about the stranded tax effects. The Company elected not to reclassify stranded tax effects from accumulated other comprehensive income to retained earnings. From time to time, new accounting guidance is issued by the FASB or other standard setting bodies that is adopted by the Company as of the effective date or, in some cases where early adoption is permitted, in advance of the effective date. The Company has assessed the recently issued guidance that is not yet effective and, unless otherwise indicated above, believes the new guidance will not have a material impact on the its consolidated results of operations, cash flows or financial position.

Net revenues (Tables)

Net revenues (Tables)	3 Months Ended
	Mar. 31, 2019
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Major Customers by Reporting Segments	The following table disaggregates revenue by global product category for the three months ended March 31, 2019 and April 1, 2018 . Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) Vascular access $ 143,897 $ 144,028 Anesthesia 80,252 84,922 Interventional 103,184 90,142 Surgical 86,719 85,621 Interventional urology 59,731 42,300 OEM 54,238 45,854 Other (1) 85,563 94,363 Net revenues (2) $ 613,584 $ 587,230 (1) Revenues in the "Other" category in the table above include revenues generated from sales of the Company’s respiratory and urology products. For the three months ended March 31, 2019, the Company reclassified its cardiac products from "Other" to "Interventional". The comparative prior year period has been restated to conform to the current period presentation. (2) The product categories listed above are presented on a global basis; in contrast, the Company’s reportable segments are defined exclusively based on the geographic location of segment operations (with the exception of the OEM reportable segment, which operates globally). The Company’s geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.

Restructuring charges and imp_2

Restructuring charges and impairment charges (Tables)	3 Months Ended
	Mar. 31, 2019
Restructuring and Related Activities [Abstract]
Restructuring and Other Impairment Charges	The following tables provide information regarding restructuring and impairment charges recognized by the Company for the three months ended March 31, 2019 and April 1, 2018 : Three Months Ended March 31, 2019 Termination benefits Other costs (1) Total (Dollars in thousands) 2019 Footprint realignment plan $ 12,975 $ — $ 12,975 2018 Footprint realignment plan $ 437 $ 574 $ 1,011 Other restructuring programs (2) 126 253 379 Restructuring charges $ 13,538 $ 827 $ 14,365 Asset impairment charges — 3,030 3,030 Restructuring and impairment charges $ 13,538 $ 3,857 $ 17,395 Three Months Ended April 1, 2018 Termination benefits Other costs (1) Total (Dollars in thousands) 2016 Footprint realignment plan (3) 1,955 194 2,149 2014 Footprint realignment plan 116 8 124 Other restructuring programs (4) 585 205 790 Restructuring charges $ 2,656 $ 407 $ 3,063 (1) Other costs include facility closure, contract termination and other exit costs. (2) Includes the Vascular Solutions integration program (initiated in 2017) as well as the 2016 and 2014 Footprint realignment plans. (3) The 2016 Footprint realignment plan involved the relocation of certain manufacturing operations, the relocation and outsourcing of certain distribution operations and a related workforce reduction at certain of the Company's facilities. The program is substantially complete and the Company expects future restructuring expenses associated with the program, if any, to be immaterial. (4) Includes the Vascular Solutions integration program and the EMEA restructuring program (both initiated in 2017).
Summary Of Current Cost Estimates By Major Type Of Cost Table	These actions are expected to be substantially completed during 2022. The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2019 Footprint realignment plan: Type of expense Total estimated amount expected to be incurred Termination benefits $19 million to $23 million Other exit costs (1) $1 million to $2 million Restructuring charges $20 million to $25 million Restructuring related charges (2) $36 million to $45 million Total restructuring and restructuring related charges $56 million to $70 million (1) Includes facility closure, employee relocation, equipment relocation and outplacement costs. (2) Restructuring related charges represent costs that are directly related to the 2019 Footprint realignment plan and principally constitute costs to transfer manufacturing operations to existing lower-cost locations, project management costs and accelerated depreciation. Most of these charges are expected to be recognized in cost of goods sold.

Inventories, net (Tables)

Inventories, net (Tables)	3 Months Ended
	Mar. 31, 2019
Inventory Disclosure [Abstract]
Inventories, net	Inventories as of March 31, 2019 and December 31, 2018 consisted of the following: March 31, 2019 December 31, 2018 (Dollars in thousands) Raw materials $ 116,257 $ 111,105 Work-in-process 69,866 62,334 Finished goods 259,443 254,339 Inventories, net $ 445,566 $ 427,778

Goodwill and other intangible_2

Goodwill and other intangible assets, net (Tables)	3 Months Ended
	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table provides information relating to changes in the carrying amount of goodwill by reportable operating segment for the three months ended March 31, 2019 : Americas EMEA Asia OEM Total (Dollars in thousands) December 31, 2018 $ 1,549,534 $ 480,615 $ 211,547 $ 4,883 $ 2,246,579 Goodwill related to acquisitions 174 75 476 — 725 Currency translation adjustment 485 (1,460 ) — 1,439 — 464 March 31, 2019 $ 1,550,193 $ 479,230 $ 213,462 $ 4,883 $ 2,247,768
Schedule of Finite-Lived Intangible Assets	The Company's gross carrying amount of, and accumulated amortization relating to, intangible assets as of March 31, 2019 and December 31, 2018 were as follows: Gross Carrying Amount Accumulated Amortization March 31, 2019 December 31, 2018 March 31, 2019 December 31, 2018 (Dollars in thousands) Customer relationships $ 1,022,131 $ 1,030,194 $ (333,633 ) $ (322,972 ) In-process research and development 28,137 28,457 — — Intellectual property 1,358,049 1,363,516 (341,986 ) (322,539 ) Distribution rights 23,405 23,465 (18,075 ) (17,860 ) Trade names 564,045 565,070 (39,904 ) (36,379 ) Non-compete agreements 22,840 23,004 (10,521 ) (8,904 ) $ 3,018,607 $ 3,033,706 $ (744,119 ) $ (708,654 )

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2019
Leases [Abstract]
Schedule of Lessee, Operating Lease, Liability, Maturity	Maturities of lease liabilities March 31, 2019 (Dollars in thousands) 2019 $ 18,674 2020 24,274 2021 21,931 2022 19,739 2023 16,137 2024 and thereafter 40,682 Total lease payments 141,437 Less: interest (20,384 ) Present value of lease liabilities 121,053
Supplemental Information, Lessee, Operating Lease	Supplemental information March 31, 2019 (Dollars in thousands) Total lease liabilities (1) $ 121,053 Cash paid for amounts included in the measurement of lease liabilities within operating cash flows $ 6,900 Right of use assets obtained in exchange for operating lease obligations $ 17,519 Weighted average remaining lease term 6.79 years Weighted average discount rate 4.23 % (1) The current portion of the operating lease liabilities of $20.3 million is included in Other current liabilities.
Future Minimum Lease Payments Under Noncancelable Operating Leases	As of December 31, 2018 , minimum lease payments under noncancellable operating leases were expected to be as follows: December 31, 2018 (Dollars in thousands) 2019 $ 25,294 2020 23,216 2021 21,419 2022 19,460 2023 17,403 2024 and thereafter 41,368

Financial instruments (Tables)

Financial instruments (Tables)	3 Months Ended
	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Values of Derivative Instruments Designated as Hedging Instruments	The following table presents the locations in the condensed consolidated balance sheet and fair value of derivative financial instruments as of March 31, 2019 and December 31, 2018 : March 31, 2019 December 31, 2018 Fair Value (Dollars in thousands) Asset derivatives: Designated foreign currency forward contracts $ 883 $ 1,216 Non-designated foreign currency forward contracts 264 106 Cross-currency interest rate swap 23,129 14,728 Prepaid expenses and other current assets 24,276 16,050 Cross-currency interest rate swap 11 — Other assets 11 — Total asset derivatives 24,287 16,050 Liability derivatives: Designated foreign currency forward contracts 1,054 524 Non-designated foreign currency forward contracts 533 264 Other current liabilities 1,587 788 Cross-currency interest rate swap 3,713 7,793 Other liabilities 3,713 7,793 Total liability derivatives $ 5,300 $ 8,581

Fair value measurement (Tables)

Fair value measurement (Tables)	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Financial Assets and Liabilities Carried at Fair Value Measured on Recurring Basis	The following tables provide information regarding the Company's financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018 : Total carrying Quoted prices in active Significant other Significant (Dollars in thousands) Investments in marketable securities $ 9,690 $ 9,690 $ — $ — Derivative assets 24,287 — 24,287 — Derivative liabilities 5,300 — 5,300 — Contingent consideration liabilities 180,362 — — 180,362 Total carrying Quoted prices in active Significant other Significant (Dollars in thousands) Investments in marketable securities $ 8,671 $ 8,671 $ — $ — Derivative assets 16,050 — 16,050 — Derivative liabilities 8,581 — 8,581 — Contingent consideration liabilities 304,248 — — 304,248
Schedule of Valuation Techniques	The table below provides additional information regarding the valuation technique and inputs used in determining the fair value of contingent consideration. Contingent Consideration Liability Valuation Technique Unobservable Input Range Milestone-based payment Discounted cash flow Discount rate 4.1% - 5.7% Projected year of payment 2019 - 2023 Revenue-based Monte Carlo simulation Revenue volatility 19.7% - 24.7% Risk free rate Cost of debt structure Projected year of payment 2020 - 2022 Discounted cash flow Discount rate 10.0% - 10.5% Projected year of payment 2019 - 2029
Reconciliation of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis	The following table provides information regarding changes in the Company's contingent consideration liabilities during the three months ended March 31, 2019 : Contingent consideration 2019 (Dollars in thousands) Balance - December 31, 2018 $ 304,248 Payments (1) (136,888 ) Revaluations 13,057 Translation adjustment (55 ) Balance - March 31, 2019 $ 180,362 (1) Consists mainly of a $106.8 million payment associated with the Company's acquisition of NeoTract, Inc. and resulting from the achievement of a sales goal for the period from January 1, 2018 to December 31, 2018 and $30.0 million of payments associated with the Company's acquisition of Essential Medical, Inc. and resulting from achievement of a regulatory goal.

Shareholders' equity (Tables)

Shareholders' equity (Tables)	3 Months Ended
	Mar. 31, 2019
Equity [Abstract]
Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding	The following table provides a reconciliation of basic to diluted weighted average number of common shares outstanding: Three Months Ended March 31, 2019 April 1, 2018 (Shares in thousands) Basic 46,050 45,329 Dilutive effect of share-based awards 892 1,044 Dilutive effect of convertible warrants — 322 Diluted 46,942 46,695
Change in Accumulated Other Comprehensive Income (Loss)	The following tables provide information relating to the changes in accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2019 and April 1, 2018 : Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2018 $ 807 $ (131,380 ) $ (210,512 ) $ (341,085 ) Other comprehensive income (loss) before reclassifications (434 ) (122 ) (236 ) (792 ) Amounts reclassified from accumulated other comprehensive income (163 ) 1,351 — 1,188 Net current-period other comprehensive income (loss) (597 ) 1,229 (236 ) 396 Balance as of March 31, 2019 $ 210 $ (130,151 ) $ (210,748 ) $ (340,689 ) Cash Flow Hedges Pension and Other Postretirement Benefit Plans Foreign Currency Translation Adjustment Accumulated Other Comprehensive (Loss) Income (Dollars in thousands) Balance as of December 31, 2017 $ 340 $ (138,808 ) $ (126,623 ) $ (265,091 ) Other comprehensive (loss) before reclassifications 1,341 (478 ) 81,188 82,051 Amounts reclassified from accumulated other comprehensive loss (720 ) 1,359 — 639 Net current-period other comprehensive income 621 881 81,188 82,690 Balance as of April 1, 2018 $ 961 $ (137,927 ) $ (45,435 ) $ (182,401 )
Reclassification of Gain/Losses into Income/Expense, Net of Tax	The following table provides information relating to the location in the statements of operations and amount of reclassifications of losses/(gains) in accumulated other comprehensive (loss) income into expense/(income), net of tax, for the three months ended March 31, 2019 and April 1, 2018 : Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) (Gains) losses on foreign exchange contracts: Cost of goods sold $ (186 ) $ (833 ) Total before tax (186 ) (833 ) Taxes (benefit) 23 113 Net of tax $ (163 ) $ (720 ) Losses (gains) on cross-currency swaps (net investment hedge): Interest expense $ (3,882 ) $ — Total before tax (3,882 ) — Tax expense 929 — Net of tax $ (2,953 ) $ — Amortization of pension and other postretirement benefit items (1): Actuarial losses $ 1,740 $ 1,746 Prior-service costs 22 24 Total before tax 1,762 1,770 Tax benefit (411 ) (411 ) Net of tax $ 1,351 $ 1,359 Total reclassifications, net of tax $ (1,765 ) $ 639 (1) These accumulated other comprehensive (loss) income components are included in the computation of net benefit expense for pension and other postretirement benefit plans.

Taxes on income from continui_2

Taxes on income from continuing operations (Tables)	3 Months Ended
	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	Three Months Ended March 31, 2019 April 1, 2018 Effective income tax rate 20.7% 10.2%

Segment information (Tables)

Segment information (Tables)	3 Months Ended
	Mar. 31, 2019
Segment Reporting [Abstract]
Segment Results	The following tables present the Company’s segment results for the three months ended March 31, 2019 and April 1, 2018 : Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) Americas $ 344,024 $ 323,262 EMEA 154,545 159,870 Asia 60,777 58,244 OEM 54,238 45,854 Net revenues $ 613,584 $ 587,230 Three Months Ended March 31, 2019 April 1, 2018 (Dollars in thousands) Americas $ 65,599 $ 58,890 EMEA 27,023 31,770 Asia 9,979 13,368 OEM 13,321 9,016 Total segment operating profit (1) 115,922 113,044 Unallocated expenses (2) (40,679 ) (26,201 ) Income from continuing operations before interest and taxes $ 75,243 $ 86,843 (1) Segment operating profit includes segment net revenues from external customers reduced by the segment's standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as net revenues, numbers of employees, and amount of time spent), depending on the category of expense involved. (2) Unallocated expenses primarily include manufacturing variances other than fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.

Condensed consolidating guara_2

Condensed consolidating guarantor financial information (Tables)	3 Months Ended
	Mar. 31, 2019
Condensed Consolidated Guarantor Financial Information [Abstract]
Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME Three Months Ended March 31, 2019 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net revenues $ — $ 415,143 $ 320,993 $ (122,552 ) $ 613,584 Cost of goods sold — 234,217 147,857 (113,232 ) 268,842 Gross profit — 180,926 173,136 (9,320 ) 344,742 Selling, general and administrative expenses 16,167 131,702 79,466 358 227,693 Research and development expenses 484 20,121 6,545 — 27,150 Restructuring and impairment charges — 5,973 11,422 — 17,395 Gain on sale of assets — — (2,739 ) — (2,739 ) (Loss) income from continuing operations before interest and taxes (16,651 ) 23,130 78,442 (9,678 ) 75,243 Interest, net 4,065 18,597 (309 ) — 22,353 (Loss) income from continuing operations before taxes (20,716 ) 4,533 78,751 (9,678 ) 52,890 (Benefit) taxes on (loss) income from continuing operations (8,872 ) 6,892 14,387 (1,435 ) 10,972 Equity in net income of consolidated subsidiaries 53,762 59,631 — (113,393 ) — Income from continuing operations 41,918 57,272 64,364 (121,636 ) 41,918 Operating loss from discontinued operations (1,343 ) — — — (1,343 ) Tax benefit on loss from discontinued operations (322 ) — — — (322 ) Loss from discontinued operations (1,021 ) — — — (1,021 ) Net income 40,897 57,272 64,364 (121,636 ) 40,897 Other comprehensive income 396 (1,501 ) (4,994 ) 6,495 396 Comprehensive income $ 41,293 $ 55,771 $ 59,370 $ (115,141 ) $ 41,293 Three Months Ended April 1, 2018 Parent Guarantor Non-Guarantor Eliminations Condensed Consolidated (Dollars in thousands) Net revenues $ — $ 379,419 $ 320,009 $ (112,198 ) $ 587,230 Cost of goods sold — 217,604 142,008 (103,652 ) 255,960 Gross profit — 161,815 178,001 (8,546 ) 331,270 Selling, general and administrative expenses 9,181 130,914 75,771 (529 ) 215,337 Research and development expenses 227 19,368 6,432 — 26,027 Restructuring charges — 908 2,155 — 3,063 (Loss) income from continuing operations before interest and taxes (9,408 ) 10,625 93,643 (8,017 ) 86,843 Interest, net 22,141 2,931 598 — 25,670 (Loss) income from continuing operations before taxes (31,549 ) 7,694 93,045 (8,017 ) 61,173 (Benefit) taxes on (loss) income from continuing operations (13,192 ) 6,423 14,177 (1,166 ) 6,242 Equity in net income of consolidated subsidiaries 74,567 76,876 293 (151,736 ) — Income from continuing operations 56,210 78,147 79,161 (158,587 ) 54,931 Operating (loss) income from discontinued operations (44 ) — 1,279 — 1,235 Tax benefit on loss from discontinued operations (18 ) — — — (18 ) (Loss) income from discontinued operations (26 ) — 1,279 — 1,253 Net income 56,184 78,147 80,440 (158,587 ) 56,184 Other comprehensive income 82,690 70,119 87,227 (157,346 ) 82,690 Comprehensive income $ 138,874 $ 148,266 $ 167,667 $ (315,933 ) $ 138,874
Condensed Consolidating Balance Sheets	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING BALANCE SHEETS March 31, 2019 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 39,022 $ 622 $ 231,568 $ — $ 271,212 Accounts receivable, net 4,286 62,457 304,037 4,976 375,756 Accounts receivable from consolidated subsidiaries 35,052 228,267 388,737 (652,056 ) — Inventories, net — 274,038 211,781 (40,253 ) 445,566 Prepaid expenses and other current assets 38,633 10,243 26,606 4,113 79,595 Prepaid taxes 4,631 — 5,854 — 10,485 Total current assets 121,624 575,627 1,168,583 (683,220 ) 1,182,614 Property, plant and equipment, net 3,167 230,983 175,813 — 409,963 Operating lease assets 14,679 62,027 35,572 — 112,278 Goodwill — 1,255,350 992,418 — 2,247,768 Intangibles assets, net 85 1,255,965 1,018,438 — 2,274,488 Investments in affiliates 6,043,371 1,771,617 — (7,814,988 ) — Deferred tax assets — — 4,885 (2,385 ) 2,500 Notes receivable and other amounts due from consolidated subsidiaries 1,976,376 2,722,166 284,413 (4,982,955 ) — Other assets 16,956 11,593 9,909 — 38,458 Total assets $ 8,176,258 $ 7,885,328 $ 3,690,031 $ (13,483,548 ) $ 6,268,069 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 36,625 $ — $ 50,000 $ — $ 86,625 Accounts payable 3,446 61,327 38,759 — 103,532 Accounts payable to consolidated subsidiaries 235,100 315,782 101,174 (652,056 ) — Accrued expenses 8,034 34,673 50,942 — 93,649 Current portion of contingent consideration — 98,622 1,064 — 99,686 Payroll and benefit-related liabilities 14,092 19,557 42,612 — 76,261 Accrued interest 23,200 — 45 — 23,245 Income taxes payable — — 8,076 (1,435 ) 6,641 Other current liabilities 4,414 14,425 12,438 — 31,277 Total current liabilities 324,911 544,386 305,110 (653,491 ) 520,916 Long-term borrowings 2,072,939 — — — 2,072,939 Deferred tax liabilities 90,195 258,470 264,326 (2,385 ) 610,606 Pension and postretirement benefit liabilities 46,154 27,162 15,971 — 89,287 Noncurrent liability for uncertain tax positions 912 7,267 2,654 — 10,833 Notes payable and other amounts due to consolidated subsidiaries 2,920,820 1,879,068 183,067 (4,982,955 ) — Noncurrent contingent consideration — 42,717 37,959 — 80,676 Noncurrent operating lease liabilities 12,218 61,390 27,100 — 100,708 Other liabilities 138,231 9,497 64,498 — 212,226 Total liabilities 5,606,380 2,829,957 900,685 (5,638,831 ) 3,698,191 Total shareholders' equity 2,569,878 5,055,371 2,789,346 (7,844,717 ) 2,569,878 Total liabilities and shareholders' equity $ 8,176,258 $ 7,885,328 $ 3,690,031 $ (13,483,548 ) $ 6,268,069 December 31, 2018 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) ASSETS Current assets Cash and cash equivalents $ 49,523 $ 1,757 $ 305,881 $ — $ 357,161 Accounts receivable, net 5,885 54,013 301,054 5,334 366,286 Accounts receivable from consolidated subsidiaries 32,036 1,043,573 350,162 (1,425,771 ) — Inventories, net — 266,073 192,659 (30,954 ) 427,778 Prepaid expenses and other current assets 30,458 9,673 28,237 4,113 72,481 Prepaid taxes 7,029 — 5,434 — 12,463 Total current assets 124,931 1,375,089 1,183,427 (1,447,278 ) 1,236,169 Property, plant and equipment, net 3,385 253,037 176,344 — 432,766 Goodwill — 1,254,848 991,731 — 2,246,579 Intangibles assets, net 90 1,277,462 1,047,500 — 2,325,052 Investments in affiliates 5,984,566 1,672,908 20,257 (7,677,731 ) — Deferred tax assets — — 4,822 (2,376 ) 2,446 Notes receivable and other amounts due from consolidated subsidiaries 2,337,737 2,523,156 13,242 (4,874,135 ) — Other assets 17,180 5,776 12,023 — 34,979 Total assets $ 8,467,889 $ 8,362,276 $ 3,449,346 $ (14,001,520 ) $ 6,277,991 LIABILITIES AND EQUITY Current liabilities Current borrowings $ 36,625 $ — $ 50,000 $ — $ 86,625 Accounts payable 3,448 62,764 40,497 — 106,709 Accounts payable to consolidated subsidiaries 1,058,008 278,715 89,048 (1,425,771 ) — Accrued expenses 5,659 41,883 50,009 — 97,551 Current portion of contingent consideration — 106,514 30,363 — 136,877 Payroll and benefit-related liabilities 17,156 44,982 42,532 — 104,670 Accrued interest 5,995 — 36 — 6,031 Income taxes payable — — 5,943 — 5,943 Other current liabilities 843 34,916 2,291 — 38,050 Total current liabilities 1,127,734 569,774 310,719 (1,425,771 ) 582,456 Long-term borrowings 2,072,200 — — — 2,072,200 Deferred tax liabilities 87,671 257,522 265,404 (2,376 ) 608,221 Pension and postretirement benefit liabilities 49,290 27,454 16,170 — 92,914 Noncurrent liability for uncertain tax positions 801 7,212 2,705 — 10,718 Notes payable and other amounts due to consolidated subsidiaries 2,451,784 2,222,580 199,771 (4,874,135 ) — Noncurrent contingent consideration — 131,563 35,807 — 167,370 Other liabilities 138,431 8,204 57,499 204,134 Total liabilities 5,927,911 3,224,309 888,075 (6,302,282 ) 3,738,013 Total shareholders' equity 2,539,978 5,137,967 2,561,271 (7,699,238 ) 2,539,978 Total liabilities and shareholders' equity $ 8,467,889 $ 8,362,276 $ 3,449,346 $ (14,001,520 ) $ 6,277,991
Condensed Consolidating Statements of Cash Flows	TELEFLEX INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Three Months Ended March 31, 2019 Parent Guarantor Non-Guarantor Eliminations Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (417 ) $ 57,823 $ 95,215 $ (92,455 ) $ 60,166 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (222 ) (17,784 ) (5,488 ) — (23,494 ) Proceeds from sale of assets and investments 2,362 991 — (2,362 ) 991 Payments for businesses and intangibles acquired, net of cash acquired — (1,025 ) — — (1,025 ) Net cash provided by (used in) investing activities from continuing operations 2,140 (17,818 ) (5,488 ) (2,362 ) (23,528 ) Cash flows from financing activities of continuing operations: Net proceeds from share based compensation plans and the related tax impacts 2,242 — — — 2,242 Payments for contingent consideration — (81,977 ) (28,976 ) — (110,953 ) Dividends paid (15,650 ) — — — (15,650 ) Intercompany transactions (2,426 ) 40,837 (40,773 ) 2,362 — Intercompany dividends paid — — (92,455 ) 92,455 — Net cash (used in) provided by financing activities from continuing operations (15,834 ) (41,140 ) (162,204 ) 94,817 (124,361 ) Cash flows from discontinued operations: Net cash provided by operating activities 3,610 — — — 3,610 Net cash provided by discontinued operations 3,610 — — — 3,610 Effect of exchange rate changes on cash and cash equivalents — — (1,836 ) — (1,836 ) Net decrease in cash and cash equivalents (10,501 ) (1,135 ) (74,313 ) — (85,949 ) Cash and cash equivalents at the beginning of the period 49,523 1,757 305,881 — 357,161 Cash and cash equivalents at the end of the period $ 39,022 $ 622 $ 231,568 $ — $ 271,212 Three Months Ended April 1, 2018 Parent Guarantor Non-Guarantor Condensed (Dollars in thousands) Net cash (used in) provided by operating activities from continuing operations $ (108,377 ) $ 134,198 $ 61,027 $ 86,848 Cash flows from investing activities of continuing operations: Expenditures for property, plant and equipment (159 ) (5,015 ) (10,573 ) (15,747 ) Payments for businesses and intangibles acquired, net of cash acquired — — (3,684 ) (3,684 ) Net cash used in investing activities from continuing operations (159 ) (5,015 ) (14,257 ) (19,431 ) Cash flows from financing activities of continuing operations: Reduction in borrowings (18,500 ) — — (18,500 ) Debt extinguishment, issuance and amendment fees (74 ) — — (74 ) Net proceeds from share based compensation plans and the related tax impacts 1,400 — — 1,400 Payments for contingent consideration — (91 ) — (91 ) Dividends paid (15,447 ) — — (15,447 ) Intercompany transactions 131,967 (127,825 ) (4,142 ) — Net cash provided by (used in) financing activities from continuing operations 99,346 (127,916 ) (4,142 ) (32,712 ) Cash flows from discontinued operations: Net cash used in operating activities (206 ) — — (206 ) Net cash used in discontinued operations (206 ) — — (206 ) Effect of exchange rate changes on cash and cash equivalents — — 10,815 10,815 Net (decrease) increase in cash and cash equivalents (9,396 ) 1,267 53,443 45,314 Cash and cash equivalents at the beginning of the period 37,803 8,933 286,822 333,558 Cash and cash equivalents at the end of the period $ 28,407 $ 10,200 $ 340,265 $ 378,872

Recently issued accounting st_3

Recently issued accounting standards (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease assets	$ 112,278
Operating lease liabilities	$ 121,053
ASU 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease assets		$ 105,300
Operating lease liabilities		$ 106,600

Net revenues (Details)

Net revenues (Details) - Sales Revenue, Net - Customer Concentration Risk	3 Months Ended
	Mar. 31, 2019
Hospitals And Healthcare Providers
Concentration Risk [Line Items]
Percentage of total revenue	87.00%
Other Medical Device Manufacturers
Concentration Risk [Line Items]
Percentage of total revenue	10.00%
Home Care Providers
Concentration Risk [Line Items]
Percentage of total revenue	3.00%

Net revenues Other revenues (De

Net revenues Other revenues (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Revenue, Major Customer [Line Items]
Net revenues	$ 613,584	$ 587,230
Vascular access
Revenue, Major Customer [Line Items]
Net revenues	143,897	144,028
Anesthesia
Revenue, Major Customer [Line Items]
Net revenues	80,252	84,922
Interventional
Revenue, Major Customer [Line Items]
Net revenues	103,184	90,142
Surgical
Revenue, Major Customer [Line Items]
Net revenues	86,719	85,621
Interventional urology
Revenue, Major Customer [Line Items]
Net revenues	59,731	42,300
OEM
Revenue, Major Customer [Line Items]
Net revenues	54,238	45,854
Other (1)
Revenue, Major Customer [Line Items]
Net revenues	$ 85,563	$ 94,363

Divestitures - Narrative (Detai

Divestitures - Narrative (Details) - USD ($) $ in Thousands	Feb. 04, 2019	Mar. 31, 2019	Apr. 01, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain (loss) on disposition of assets		$ 2,739	$ 0
Notes Receivable
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Receivable with imputed interest, face amount	$ 10,500
Financing receivables, payments to be received in next twelve months		2,100
Notes receivable, fair value disclosure	7,600
Financing receivable, net		7,800
Financing receivables, payments to be received in year two		2,100
Financing receivables, payments to be received in year three		2,100
Financing receivables, payments to be received in year four		2,100
Financing receivables, payments to be received in year five		2,100
Notes Receivable | Accounts Receivable
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Financing receivable, net		1,900
Notes Receivable | Other Assets
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Financing receivable, net		5,900
Disposal Group, Disposed of by Sale, Not Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal group, including discontinued operation, consideration	12,600
Gain (loss) on disposition of assets	$ 2,700
Disposal group, including discontinued operation, assets		$ 9,700

Restructuring charges and imp_3

Restructuring charges and impairment charges - Charges Recognized (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 14,365	$ 3,063
Asset impairment charges	3,030
Restructuring and impairment charges	17,395	3,063
Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	13,538	2,656
Asset impairment charges	0
Restructuring and impairment charges	13,538
Other Restructuring costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	827	407
Asset impairment charges	3,030
Restructuring and impairment charges	3,857
2019 Footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	12,975
2019 Footprint realignment plan | Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	12,975
2019 Footprint realignment plan | Other Restructuring costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0
2018 Footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,011
2018 Footprint realignment plan | Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	437
2018 Footprint realignment plan | Other Restructuring costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	574
Other restructuring programs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	379	790
Other restructuring programs | Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	126	585
Other restructuring programs | Other Restructuring costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 253	205
2016 Footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges		2,149
2016 Footprint realignment plan | Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		1,955
2016 Footprint realignment plan | Other Restructuring costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		194
2014 Footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges		124
2014 Footprint realignment plan | Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		116
2014 Footprint realignment plan | Other Restructuring costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 8

Restructuring charges and imp_4

Restructuring charges and impairment charges - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018	May 01, 2018
2019 Footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs expected cash payment	$ 0.6
Restructuring reserve	12.5
2019 Footprint realignment plan | Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges			$ 56
2019 Footprint realignment plan | Minimum | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges			36
2019 Footprint realignment plan | Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges			70
2019 Footprint realignment plan | Maximum | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges			$ 45
2018 Footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs expected cash payment	0.6
Restructuring reserve	47.5
Aggregate restructuring charges incurred	56
Restructuring expenses	4.7
2018 Footprint realignment plan | Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	102
2018 Footprint realignment plan | Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	133
2014 Footprint realignment plan
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	3.8
Aggregate restructuring charges incurred	12.7
Restructuring expenses	29.8
2014 Footprint realignment plan | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	0.7	$ 0.4
2014 Footprint realignment plan | Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	47
2014 Footprint realignment plan | Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	$ 52

Restructuring charges and imp_5

Restructuring charges and impairment charges - Cost Estimates By Major Type of Expense (Details) - 2019 Footprint realignment plan $ in Millions	May 01, 2018USD ($)
Minimum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	$ 56
Minimum | Termination benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	19
Minimum | Other exit costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	1
Minimum | Special Termination Benefit And Other Restructuring
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	20
Minimum | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	36
Maximum
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	70
Maximum | Termination benefits
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	23
Maximum | Other exit costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	2
Maximum | Special Termination Benefit And Other Restructuring
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	25
Maximum | Accelerated Depreciation And Other Costs
Restructuring Cost and Reserve [Line Items]
Expected restructuring charges	$ 45

Inventories, net (Detail)

Inventories, net (Detail) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 116,257	$ 111,105
Work-in-process	69,866	62,334
Finished goods	259,443	254,339
Inventories, net	$ 445,566	$ 427,778

Goodwill and other intangible_3

Goodwill and other intangible assets, net - Changes in carrying amount of goodwill, by reporting segment (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 2,246,579
Goodwill related to acquisitions	725
Currency translation adjustment	464
Goodwill, ending balance	2,247,768
Americas
Goodwill [Roll Forward]
Goodwill, beginning balance	1,549,534
Goodwill related to acquisitions	174
Currency translation adjustment	485
Goodwill, ending balance	1,550,193
EMEA
Goodwill [Roll Forward]
Goodwill, beginning balance	480,615
Goodwill related to acquisitions	75
Currency translation adjustment	(1,460)
Goodwill, ending balance	479,230
Asia
Goodwill [Roll Forward]
Goodwill, beginning balance	211,547
Goodwill related to acquisitions	476
Currency translation adjustment	1,439
Goodwill, ending balance	213,462
OEM
Goodwill [Roll Forward]
Goodwill, beginning balance	4,883
Goodwill related to acquisitions	0
Currency translation adjustment	0
Goodwill, ending balance	$ 4,883

Goodwill and other intangible_4

Goodwill and other intangible assets, net - Components of intangible assets (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 3,018,607	$ 3,033,706
Accumulated Amortization	(744,119)	(708,654)
In-process research and development
Finite-Lived Intangible Assets [Line Items]
In-process research and development	28,137	28,457
Accumulated Amortization	0	0
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets	1,022,131	1,030,194
Accumulated Amortization	(333,633)	(322,972)
Intellectual property
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets	1,358,049	1,363,516
Accumulated Amortization	(341,986)	(322,539)
Distribution rights
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets	23,405	23,465
Accumulated Amortization	(18,075)	(17,860)
Trade names
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets	564,045	565,070
Accumulated Amortization	(39,904)	(36,379)
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets	22,840	23,004
Accumulated Amortization	$ (10,521)	$ (8,904)

Leases (Details)

Leases (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Lessee, Lease, Description [Line Items]
Lease, cost	$ 6.1
Minimum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, option to terminate or extend	1 year

Leases Maturities of lease liab

Leases Maturities of lease liabilities (Details) $ in Thousands	Mar. 31, 2019USD ($)
Leases [Abstract]
2019	$ 18,674
2020	24,274
2021	21,931
2022	19,739
2023	16,137
2024 and thereafter	40,682
Total lease payments	141,437
Less: interest	(20,384)
Present value of lease liabilities	$ 121,053

Leases Supplemental balance she

Leases Supplemental balance sheet information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019USD ($)
Leases [Abstract]
Operating lease liabilities	$ 121,053
Cash paid for amounts included in the measurement of lease liabilities within operating cash flows	6,900
Right of use assets obtained in exchange for operating lease obligations	$ 17,519
Weighted average remaining lease term	6 years 9 months 14 days
Weighted average discount rate	4.23%
Other current liabilities
Lessee, Lease, Description [Line Items]
Current operating lease liabilities	$ 20,300

Leases - Future minimum lease p

Leases - Future minimum lease payments under noncancelable operating leases (Details) $ in Thousands	Dec. 31, 2018USD ($)
Leases [Abstract]
2019	$ 25,294
2020	23,216
2021	21,419
2022	19,460
2023	17,403
2024 and thereafter	$ 41,368

Financial instruments - Additio

Financial instruments - Additional Information (Details)	3 Months Ended
	Mar. 31, 2019USD ($)	Apr. 01, 2018USD ($)	Mar. 31, 2019EUR (€)	Mar. 04, 2019	Dec. 31, 2018USD ($)	Oct. 04, 2018USD ($)	Oct. 04, 2018EUR (€)
Derivatives Fair Value [Line Items]
Foreign currency translation, continuing operations, adjustments, net of tax	$ (236,000)	$ 81,188,000
Net revenues	613,584,000	587,230,000
Cash flow hedging
Derivatives Fair Value [Line Items]
Ineffectiveness related to derivatives	0	0
Foreign exchange contract | Designated as Hedging Instrument | Cash flow hedging
Derivatives Fair Value [Line Items]
Total notional amount for all open foreign currency forward contracts	63,400,000				$ 115,300,000
Foreign exchange contract | Not Designated as Hedging Instrument
Derivatives Fair Value [Line Items]
Loss related to currency forward contracts	3,000,000	$ 600,000
Total notional amount for all open foreign currency forward contracts	132,800,000				$ 125,900,000
Cross-currency interest rate swap | Cash flow hedging
Derivatives Fair Value [Line Items]
Foreign currency translation, continuing operations, adjustments, net of tax	10,600,000
Cross-currency interest rate swap | Designated as Hedging Instrument
Derivatives Fair Value [Line Items]
Total notional amount for all open foreign currency forward contracts	$ 250,000,000		€ 219,200,000			$ 500,000,000	€ 433,900,000
Derivative, number of instruments held				5		6	6
Derivative, fixed interest rate	4.875%		4.875%			4.625%	4.625%
Derivative, annual interest rate	2.4595%		2.4595%			1.942%	1.942%

Financial instruments - Fair va

Financial instruments - Fair values of derivative instruments designated as hedging instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Cash flow hedging
Derivatives Fair Value [Line Items]
Total asset derivatives	$ 24,287	$ 16,050
Total liability derivatives	5,300	8,581
Foreign exchange contract | Other liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	3,713	7,793
Foreign exchange contract | Cash flow hedging | Prepaid expenses and other current assets
Derivatives Fair Value [Line Items]
Total asset derivatives	24,276	16,050
Foreign exchange contract | Cash flow hedging | Other assets
Derivatives Fair Value [Line Items]
Total asset derivatives	11	0
Foreign exchange contract | Cash flow hedging | Other current liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	1,587	788
Foreign exchange contract | Designated as Hedging Instrument | Cash flow hedging | Prepaid expenses and other current assets
Derivatives Fair Value [Line Items]
Total asset derivatives	883	1,216
Foreign exchange contract | Designated as Hedging Instrument | Cash flow hedging | Other current liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	1,054	524
Foreign exchange contract | Not Designated as Hedging Instrument | Cash flow hedging | Prepaid expenses and other current assets
Derivatives Fair Value [Line Items]
Total asset derivatives	264	106
Foreign exchange contract | Not Designated as Hedging Instrument | Cash flow hedging | Other current liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	533	264
Cross-currency interest rate swap | Cash flow hedging | Prepaid expenses and other current assets
Derivatives Fair Value [Line Items]
Total asset derivatives	23,129	14,728
Cross-currency interest rate swap | Cash flow hedging | Other assets
Derivatives Fair Value [Line Items]
Total asset derivatives	11	0
Cross-currency interest rate swap | Cash flow hedging | Other liabilities
Derivatives Fair Value [Line Items]
Total liability derivatives	$ 3,713	$ 7,793

Fair value measurement - Financ

Fair value measurement - Financial assets and liabilities carried at fair value measured on recurring basis (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	$ 9,690	$ 8,671
Derivative assets	24,287	16,050
Derivative liabilities	5,300	8,581
Contingent consideration liabilities	180,362	304,248
Quoted prices in active markets (Level 1)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	9,690	8,671
Derivative assets	0	0
Derivative liabilities	0	0
Contingent consideration liabilities	0	0
Significant other observable Inputs (Level 2)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Derivative assets	24,287	16,050
Derivative liabilities	5,300	8,581
Contingent consideration liabilities	0	0
Significant unobservable Inputs (Level 3)
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Investments in marketable securities	0	0
Derivative assets	0	0
Derivative liabilities	0	0
Contingent consideration liabilities	$ 180,362	$ 304,248

Fair value measurement - Narrat

Fair value measurement - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
NeoTract
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Milestone payment	$ 106.8
Essential Medical, Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Milestone payment	$ 30

Fair value measurement - Valuat

Fair value measurement - Valuation technique and inputs used in determining the fair value of contingent consideration (Details)	Mar. 31, 2019
Milestone-based payment | Minimum | Discounted cash flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Business combination, contingent consideration, liability, measurement input	0.041
Milestone-based payment | Maximum | Discounted cash flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Business combination, contingent consideration, liability, measurement input	0.057
Revenue-based | Minimum | Discounted cash flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Business combination, contingent consideration, liability, measurement input	0.100
Revenue-based | Minimum | Monte Carlo simulation | Revenue volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Business combination, contingent consideration, liability, measurement input	0.197
Revenue-based | Maximum | Discounted cash flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Business combination, contingent consideration, liability, measurement input	0.105
Revenue-based | Maximum | Monte Carlo simulation | Revenue volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Business combination, contingent consideration, liability, measurement input	0.247

Fair value measurement - Reconc

Fair value measurement - Reconciliation of changes in financial liabilities measured on recurring basis (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 304,248
Payments	(136,888)
Revaluations	13,057
Translation adjustment	(55)
Ending balance	$ 180,362

Shareholders' equity - Addition

Shareholders' equity - Additional Information (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Equity Option
Shareholders Equity [Line Items]
Weighted average antidilutive shares which were not included in the calculation of earnings per share	0.1	0.6

Shareholders' equity - Reconcil

Shareholders' equity - Reconciliation of basic to diluted weighted average common shares outstanding (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Equity [Abstract]
Basic (in shares)	46,050	45,329
Dilutive effect of share-based awards (in shares)	892	1,044
Dilutive effect of convertible notes and warrants (in shares)	0	322
Diluted (in shares)	46,942	46,695

Shareholders' equity - Change i

Shareholders' equity - Change in accumulated other comprehensive income, net of tax (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	$ 2,539,978	$ 2,430,531
Amounts reclassified from accumulated other comprehensive income	(1,765)	639
Ending Balance	2,569,878	2,560,500
Cash Flow Hedges
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	807	340
Other comprehensive income (loss) before reclassifications	(434)	1,341
Amounts reclassified from accumulated other comprehensive income	(163)	(720)
Net current-period other comprehensive income (loss)	(597)	621
Ending Balance	210	961
Pension and Other Postretirement Benefit Plans
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(131,380)	(138,808)
Other comprehensive income (loss) before reclassifications	(122)	(478)
Amounts reclassified from accumulated other comprehensive income	1,351	1,359
Net current-period other comprehensive income (loss)	1,229	881
Ending Balance	(130,151)	(137,927)
Foreign Currency Translation Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(210,512)	(126,623)
Other comprehensive income (loss) before reclassifications	(236)	81,188
Amounts reclassified from accumulated other comprehensive income	0	0
Net current-period other comprehensive income (loss)	(236)	81,188
Ending Balance	(210,748)	(45,435)
Accumulated Other Comprehensive (Loss) Income
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(341,085)	(265,091)
Other comprehensive income (loss) before reclassifications	(792)	82,051
Amounts reclassified from accumulated other comprehensive income	1,188	639
Net current-period other comprehensive income (loss)	396	82,690
Ending Balance	$ (340,689)	$ (182,401)

Shareholders' equity - Accumula

Shareholders' equity - Accumulated other comprehensive income into income expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold	$ 268,842	$ 255,960
Total before tax	(52,890)	(61,173)
Taxes on income from continuing operations	(10,972)	(6,242)
Net of tax	(41,918)	(54,931)
Interest expense	22,692	25,943
Total reclassifications, net of tax	(1,765)	639
Actuarial losses
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,740	1,746
Prior-service costs
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	22	24
Pension and Other Postretirement Benefits Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	1,762	1,770
Tax benefit	(411)	(411)
Total reclassifications, net of tax	1,351	1,359
Reclassification out of Accumulated Other Comprehensive Income | Foreign exchange contract | Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cost of goods sold	(186)	(833)
Total before tax	(186)	(833)
Taxes on income from continuing operations	(23)	(113)
Net of tax	(163)	(720)
Reclassification out of Accumulated Other Comprehensive Income | Cross-currency interest rate swap | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total before tax	3,882	0
Taxes on income from continuing operations	929	0
Net of tax	2,953	0
Interest expense	$ (3,882)	$ 0

Taxes on income from continui_3

Taxes on income from continuing operations (Details)	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Income Tax Disclosure [Abstract]
Effective income tax rate	20.70%	10.20%

Commitments and contingent li_2

Commitments and contingent liabilities (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)
Loss Contingencies [Line Items]
Estimated litigation liability	$ 0.4
Minimum
Loss Contingencies [Line Items]
Estimated time fram over which accrued amounts may be paid out	10 years
Maximum
Loss Contingencies [Line Items]
Estimated time fram over which accrued amounts may be paid out	15 years
Accrued Liabilities
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 0.9
Other Liability
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 6.6

Segment information (Details)

Segment information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	$ 613,584	$ 587,230
Operating profit	75,243	86,843
Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	115,922	113,044
Unallocated expenses
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	(40,679)	(26,201)
Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	344,024	323,262
Americas | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	65,599	58,890
EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	154,545	159,870
EMEA | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	27,023	31,770
Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	60,777	58,244
Asia | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	9,979	13,368
OEM
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenues	54,238	45,854
OEM | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Operating profit	$ 13,321	$ 9,016

Condensed consolidating guara_3

Condensed consolidating guarantor financial information - Additional Information (Detail)	Dec. 31, 2018
Condensed Consolidated Guarantor Financial Information [Abstract]
Ownership percentage	100.00%

Condensed consolidating guara_4

Condensed consolidating guarantor financial information - Income and Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Condensed Income Statements, Captions [Line Items]
Net revenues	$ 613,584	$ 587,230
Cost of goods sold	268,842	255,960
Gross profit	344,742	331,270
Selling, general and administrative expenses	227,693	215,337
Research and development expenses	27,150	26,027
Restructuring and impairment charges	17,395	3,063
Gain on sale of assets	(2,739)	0
Income from continuing operations before interest and taxes	75,243	86,843
Interest, net	22,353	25,670
Income from continuing operations before taxes	52,890	61,173
(Benefit) taxes on (loss) income from continuing operations	10,972	6,242
Equity in net income of consolidated subsidiaries	0	0
Income from continuing operations	41,918	54,931
Operating loss from discontinued operations	(1,343)	1,235
Benefit on loss from discontinued operations	(322)	(18)
Income (loss) from discontinued operations	(1,021)	1,253
Net income	40,897	56,184
Other comprehensive income	396	82,690
Comprehensive income	41,293	138,874
Eliminations
Condensed Income Statements, Captions [Line Items]
Net revenues	(122,552)	(112,198)
Cost of goods sold	(113,232)	(103,652)
Gross profit	(9,320)	(8,546)
Selling, general and administrative expenses	358	(529)
Research and development expenses	0	0
Restructuring and impairment charges	0	0
Gain on sale of assets	0
Income from continuing operations before interest and taxes	(9,678)	(8,017)
Interest, net	0	0
Income from continuing operations before taxes	(9,678)	(8,017)
(Benefit) taxes on (loss) income from continuing operations	(1,435)	(1,166)
Equity in net income of consolidated subsidiaries	(113,393)	(151,736)
Income from continuing operations	(121,636)	(158,587)
Operating loss from discontinued operations	0	0
Benefit on loss from discontinued operations	0	0
Income (loss) from discontinued operations	0	0
Net income	(121,636)	(158,587)
Other comprehensive income	6,495	(157,346)
Comprehensive income	(115,141)	(315,933)
Parent Company
Condensed Income Statements, Captions [Line Items]
Net revenues	0	0
Cost of goods sold	0	0
Gross profit	0	0
Selling, general and administrative expenses	16,167	9,181
Research and development expenses	484	227
Restructuring and impairment charges	0	0
Gain on sale of assets	0
Income from continuing operations before interest and taxes	(16,651)	(9,408)
Interest, net	4,065	22,141
Income from continuing operations before taxes	(20,716)	(31,549)
(Benefit) taxes on (loss) income from continuing operations	(8,872)	(13,192)
Equity in net income of consolidated subsidiaries	53,762	74,567
Income from continuing operations	41,918	56,210
Operating loss from discontinued operations	(1,343)	(44)
Benefit on loss from discontinued operations	(322)	(18)
Income (loss) from discontinued operations	(1,021)	(26)
Net income	40,897	56,184
Other comprehensive income	396	82,690
Comprehensive income	41,293	138,874
Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Net revenues	415,143	379,419
Cost of goods sold	234,217	217,604
Gross profit	180,926	161,815
Selling, general and administrative expenses	131,702	130,914
Research and development expenses	20,121	19,368
Restructuring and impairment charges	5,973	908
Gain on sale of assets	0
Income from continuing operations before interest and taxes	23,130	10,625
Interest, net	18,597	2,931
Income from continuing operations before taxes	4,533	7,694
(Benefit) taxes on (loss) income from continuing operations	6,892	6,423
Equity in net income of consolidated subsidiaries	59,631	76,876
Income from continuing operations	57,272	78,147
Operating loss from discontinued operations	0	0
Benefit on loss from discontinued operations	0	0
Income (loss) from discontinued operations	0	0
Net income	57,272	78,147
Other comprehensive income	(1,501)	70,119
Comprehensive income	55,771	148,266
Non-Guarantor Subsidiaries
Condensed Income Statements, Captions [Line Items]
Net revenues	320,993	320,009
Cost of goods sold	147,857	142,008
Gross profit	173,136	178,001
Selling, general and administrative expenses	79,466	75,771
Research and development expenses	6,545	6,432
Restructuring and impairment charges	11,422	2,155
Gain on sale of assets	(2,739)
Income from continuing operations before interest and taxes	78,442	93,643
Interest, net	(309)	598
Income from continuing operations before taxes	78,751	93,045
(Benefit) taxes on (loss) income from continuing operations	14,387	14,177
Equity in net income of consolidated subsidiaries	0	293
Income from continuing operations	64,364	79,161
Operating loss from discontinued operations	0	1,279
Benefit on loss from discontinued operations	0	0
Income (loss) from discontinued operations	0	1,279
Net income	64,364	80,440
Other comprehensive income	(4,994)	87,227
Comprehensive income	$ 59,370	$ 167,667

Condensed consolidating guara_5

Condensed consolidating guarantor financial information - Balance Sheets (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018	Apr. 01, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 271,212	$ 357,161	$ 378,872	$ 333,558
Accounts receivable, net of allowances of $9,225 and $9,348, respectively	375,756	366,286
Accounts receivable from consolidated subsidiaries	0	0
Inventories, net	445,566	427,778
Prepaid expenses and other current assets	79,595	72,481
Prepaid taxes	10,485	12,463
Total current assets	1,182,614	1,236,169
Property, plant and equipment, net	409,963	432,766
Operating lease assets	112,278
Goodwill	2,247,768	2,246,579
Intangible assets, net	2,274,488	2,325,052
Investments in affiliates	0	0
Deferred tax assets	2,500	2,446
Notes receivable and other amounts due from consolidated subsidiaries	0	0
Other assets	38,458	34,979
Total assets	6,268,069	6,277,991
Current liabilities
Current borrowings	86,625	86,625
Accounts payable	103,532	106,709
Accounts payable to consolidated subsidiaries	0	0
Accrued expenses	93,649	97,551
Current portion of contingent consideration	99,686	136,877
Payroll and benefit-related liabilities	76,261	104,670
Accrued interest	23,245	6,031
Income taxes payable	6,641	5,943
Other current liabilities	31,277	38,050
Total current liabilities	520,916	582,456
Long-term borrowings	2,072,939	2,072,200
Deferred tax liabilities	610,606	608,221
Pension and postretirement benefit liabilities	89,287	92,914
Noncurrent liability for uncertain tax positions	10,833	10,718
Notes payable and other amounts due to consolidated subsidiaries	0	0
Noncurrent contingent consideration	80,676	167,370
Noncurrent operating lease liabilities	100,708
Other liabilities	212,226	204,134
Total liabilities	3,698,191	3,738,013
Total shareholders' equity	2,569,878	2,539,978
Total liabilities and shareholders' equity	6,268,069	6,277,991
Eliminations
Current assets
Cash and cash equivalents	0	0
Accounts receivable, net of allowances of $9,225 and $9,348, respectively	4,976	5,334
Accounts receivable from consolidated subsidiaries	(652,056)	(1,425,771)
Inventories, net	(40,253)	(30,954)
Prepaid expenses and other current assets	4,113	4,113
Prepaid taxes	0	0
Total current assets	(683,220)	(1,447,278)
Property, plant and equipment, net	0	0
Operating lease assets	0
Goodwill	0	0
Intangible assets, net	0	0
Investments in affiliates	(7,814,988)	(7,677,731)
Deferred tax assets	(2,385)	(2,376)
Notes receivable and other amounts due from consolidated subsidiaries	(4,982,955)	(4,874,135)
Other assets	0	0
Total assets	(13,483,548)	(14,001,520)
Current liabilities
Current borrowings	0	0
Accounts payable	0	0
Accounts payable to consolidated subsidiaries	(652,056)	(1,425,771)
Accrued expenses	0	0
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	0	0
Accrued interest	0	0
Income taxes payable	(1,435)	0
Other current liabilities	0	0
Total current liabilities	(653,491)	(1,425,771)
Long-term borrowings	0	0
Deferred tax liabilities	(2,385)	(2,376)
Pension and postretirement benefit liabilities	0	0
Noncurrent liability for uncertain tax positions	0	0
Notes payable and other amounts due to consolidated subsidiaries	(4,982,955)	(4,874,135)
Noncurrent contingent consideration	0	0
Noncurrent operating lease liabilities	0
Other liabilities	0
Total liabilities	(5,638,831)	(6,302,282)
Total shareholders' equity	(7,844,717)	(7,699,238)
Total liabilities and shareholders' equity	(13,483,548)	(14,001,520)
Parent Company
Current assets
Cash and cash equivalents	39,022	49,523	28,407	37,803
Accounts receivable, net of allowances of $9,225 and $9,348, respectively	4,286	5,885
Accounts receivable from consolidated subsidiaries	35,052	32,036
Inventories, net	0	0
Prepaid expenses and other current assets	38,633	30,458
Prepaid taxes	4,631	7,029
Total current assets	121,624	124,931
Property, plant and equipment, net	3,167	3,385
Operating lease assets	14,679
Goodwill	0	0
Intangible assets, net	85	90
Investments in affiliates	6,043,371	5,984,566
Deferred tax assets	0	0
Notes receivable and other amounts due from consolidated subsidiaries	1,976,376	2,337,737
Other assets	16,956	17,180
Total assets	8,176,258	8,467,889
Current liabilities
Current borrowings	36,625	36,625
Accounts payable	3,446	3,448
Accounts payable to consolidated subsidiaries	235,100	1,058,008
Accrued expenses	8,034	5,659
Current portion of contingent consideration	0	0
Payroll and benefit-related liabilities	14,092	17,156
Accrued interest	23,200	5,995
Income taxes payable	0	0
Other current liabilities	4,414	843
Total current liabilities	324,911	1,127,734
Long-term borrowings	2,072,939	2,072,200
Deferred tax liabilities	90,195	87,671
Pension and postretirement benefit liabilities	46,154	49,290
Noncurrent liability for uncertain tax positions	912	801
Notes payable and other amounts due to consolidated subsidiaries	2,920,820	2,451,784
Noncurrent contingent consideration	0	0
Noncurrent operating lease liabilities	12,218
Other liabilities	138,231	138,431
Total liabilities	5,606,380	5,927,911
Total shareholders' equity	2,569,878	2,539,978
Total liabilities and shareholders' equity	8,176,258	8,467,889
Guarantor Subsidiaries
Current assets
Cash and cash equivalents	622	1,757	10,200	8,933
Accounts receivable, net of allowances of $9,225 and $9,348, respectively	62,457	54,013
Accounts receivable from consolidated subsidiaries	228,267	1,043,573
Inventories, net	274,038	266,073
Prepaid expenses and other current assets	10,243	9,673
Prepaid taxes	0	0
Total current assets	575,627	1,375,089
Property, plant and equipment, net	230,983	253,037
Operating lease assets	62,027
Goodwill	1,255,350	1,254,848
Intangible assets, net	1,255,965	1,277,462
Investments in affiliates	1,771,617	1,672,908
Deferred tax assets	0	0
Notes receivable and other amounts due from consolidated subsidiaries	2,722,166	2,523,156
Other assets	11,593	5,776
Total assets	7,885,328	8,362,276
Current liabilities
Current borrowings	0	0
Accounts payable	61,327	62,764
Accounts payable to consolidated subsidiaries	315,782	278,715
Accrued expenses	34,673	41,883
Current portion of contingent consideration	98,622	106,514
Payroll and benefit-related liabilities	19,557	44,982
Accrued interest	0	0
Income taxes payable	0	0
Other current liabilities	14,425	34,916
Total current liabilities	544,386	569,774
Long-term borrowings	0	0
Deferred tax liabilities	258,470	257,522
Pension and postretirement benefit liabilities	27,162	27,454
Noncurrent liability for uncertain tax positions	7,267	7,212
Notes payable and other amounts due to consolidated subsidiaries	1,879,068	2,222,580
Noncurrent contingent consideration	42,717	131,563
Noncurrent operating lease liabilities	61,390
Other liabilities	9,497	8,204
Total liabilities	2,829,957	3,224,309
Total shareholders' equity	5,055,371	5,137,967
Total liabilities and shareholders' equity	7,885,328	8,362,276
Non-Guarantor Subsidiaries
Current assets
Cash and cash equivalents	231,568	305,881	$ 340,265	$ 286,822
Accounts receivable, net of allowances of $9,225 and $9,348, respectively	304,037	301,054
Accounts receivable from consolidated subsidiaries	388,737	350,162
Inventories, net	211,781	192,659
Prepaid expenses and other current assets	26,606	28,237
Prepaid taxes	5,854	5,434
Total current assets	1,168,583	1,183,427
Property, plant and equipment, net	175,813	176,344
Operating lease assets	35,572
Goodwill	992,418	991,731
Intangible assets, net	1,018,438	1,047,500
Investments in affiliates	0	20,257
Deferred tax assets	4,885	4,822
Notes receivable and other amounts due from consolidated subsidiaries	284,413	13,242
Other assets	9,909	12,023
Total assets	3,690,031	3,449,346
Current liabilities
Current borrowings	50,000	50,000
Accounts payable	38,759	40,497
Accounts payable to consolidated subsidiaries	101,174	89,048
Accrued expenses	50,942	50,009
Current portion of contingent consideration	1,064	30,363
Payroll and benefit-related liabilities	42,612	42,532
Accrued interest	45	36
Income taxes payable	8,076	5,943
Other current liabilities	12,438	2,291
Total current liabilities	305,110	310,719
Long-term borrowings	0	0
Deferred tax liabilities	264,326	265,404
Pension and postretirement benefit liabilities	15,971	16,170
Noncurrent liability for uncertain tax positions	2,654	2,705
Notes payable and other amounts due to consolidated subsidiaries	183,067	199,771
Noncurrent contingent consideration	37,959	35,807
Noncurrent operating lease liabilities	27,100
Other liabilities	64,498	57,499
Total liabilities	900,685	888,075
Total shareholders' equity	2,789,346	2,561,271
Total liabilities and shareholders' equity	$ 3,690,031	$ 3,449,346

Condensed consolidating guara_6

Condensed consolidating guarantor financial information - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Apr. 01, 2018
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations	$ 60,166	$ 86,848
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(23,494)	(15,747)
Proceeds from sale of assets and investments	991	0
Payments for businesses and intangibles acquired, net of cash acquired	(1,025)	(3,684)
Net cash used in investing activities from continuing operations	(23,528)	(19,431)
Cash flows from financing activities of continuing operations:
Net proceeds from share based compensation plans and the related tax impacts	2,242	1,400
Payments for contingent consideration	(110,953)	(91)
Dividends paid	(15,650)	(15,447)
Intercompany transactions	0	0
Intercompany dividends paid	0
Reduction in borrowings	0	(18,500)
Debt extinguishment, issuance and amendment fees	0	(74)
Net cash provided by (used in) financing activities from continuing operations	(124,361)	(32,712)
Cash flows from discontinued operations:
Net cash used in operating activities	3,610	(206)
Net cash used in discontinued operations	3,610	(206)
Effect of exchange rate changes on cash and cash equivalents	(1,836)	10,815
Net (decrease) increase in cash and cash equivalents	(85,949)	45,314
Cash and cash equivalents at the beginning of the period	357,161	333,558
Cash and cash equivalents at the end of the period	271,212	378,872
Eliminations
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations	(92,455)
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	0
Proceeds from sale of assets and investments	(2,362)
Payments for businesses and intangibles acquired, net of cash acquired	0
Net cash used in investing activities from continuing operations	(2,362)
Cash flows from financing activities of continuing operations:
Net proceeds from share based compensation plans and the related tax impacts	0
Payments for contingent consideration	0
Dividends paid	0
Intercompany transactions	2,362
Intercompany dividends paid	92,455
Net cash provided by (used in) financing activities from continuing operations	94,817
Cash flows from discontinued operations:
Net cash used in operating activities	0
Net cash used in discontinued operations	0
Effect of exchange rate changes on cash and cash equivalents	0
Net (decrease) increase in cash and cash equivalents	0
Cash and cash equivalents at the beginning of the period	0
Cash and cash equivalents at the end of the period	0
Parent Company
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations	(417)	(108,377)
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(222)	(159)
Proceeds from sale of assets and investments	2,362
Payments for businesses and intangibles acquired, net of cash acquired	0	0
Net cash used in investing activities from continuing operations	2,140	(159)
Cash flows from financing activities of continuing operations:
Net proceeds from share based compensation plans and the related tax impacts	2,242	1,400
Payments for contingent consideration	0	0
Dividends paid	(15,650)	(15,447)
Intercompany transactions	(2,426)	131,967
Intercompany dividends paid	0
Reduction in borrowings		(18,500)
Debt extinguishment, issuance and amendment fees		(74)
Net cash provided by (used in) financing activities from continuing operations	(15,834)	99,346
Cash flows from discontinued operations:
Net cash used in operating activities	3,610	(206)
Net cash used in discontinued operations	3,610	(206)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	(10,501)	(9,396)
Cash and cash equivalents at the beginning of the period	49,523	37,803
Cash and cash equivalents at the end of the period	39,022	28,407
Guarantor Subsidiaries
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations	57,823	134,198
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(17,784)	(5,015)
Proceeds from sale of assets and investments	991
Payments for businesses and intangibles acquired, net of cash acquired	(1,025)	0
Net cash used in investing activities from continuing operations	(17,818)	(5,015)
Cash flows from financing activities of continuing operations:
Net proceeds from share based compensation plans and the related tax impacts	0	0
Payments for contingent consideration	(81,977)	(91)
Dividends paid	0	0
Intercompany transactions	40,837	(127,825)
Intercompany dividends paid	0
Reduction in borrowings		0
Debt extinguishment, issuance and amendment fees		0
Net cash provided by (used in) financing activities from continuing operations	(41,140)	(127,916)
Cash flows from discontinued operations:
Net cash used in operating activities	0	0
Net cash used in discontinued operations	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	(1,135)	1,267
Cash and cash equivalents at the beginning of the period	1,757	8,933
Cash and cash equivalents at the end of the period	622	10,200
Non-Guarantor Subsidiaries
Condensed Cash Flow Statements, Captions [Line Items]
Net cash (used in) provided by operating activities from continuing operations	95,215	61,027
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment	(5,488)	(10,573)
Proceeds from sale of assets and investments	0
Payments for businesses and intangibles acquired, net of cash acquired	0	(3,684)
Net cash used in investing activities from continuing operations	(5,488)	(14,257)
Cash flows from financing activities of continuing operations:
Net proceeds from share based compensation plans and the related tax impacts	0	0
Payments for contingent consideration	(28,976)	0
Dividends paid	0	0
Intercompany transactions	(40,773)	(4,142)
Intercompany dividends paid	(92,455)
Reduction in borrowings		0
Debt extinguishment, issuance and amendment fees		0
Net cash provided by (used in) financing activities from continuing operations	(162,204)	(4,142)
Cash flows from discontinued operations:
Net cash used in operating activities	0	0
Net cash used in discontinued operations	0	0
Effect of exchange rate changes on cash and cash equivalents	(1,836)	10,815
Net (decrease) increase in cash and cash equivalents	(74,313)	53,443
Cash and cash equivalents at the beginning of the period	305,881	286,822
Cash and cash equivalents at the end of the period	$ 231,568	$ 340,265

Subsequent event - Narrative (D

Subsequent event - Narrative (Details) - Subsequent event - Second Amended and Restated Credit Agreement	Apr. 05, 2019USD ($)
Subsequent Event [Line Items]
Debt instrument term	5 years
Debt instrument, stated interest rate	2.00%
Maximum leverage ratio	4.50
Minimum interest coverage ratio	3.50
London Interbank Offered Rate (LIBOR) | Minimum
Subsequent Event [Line Items]
Basis spread on variable rate	1.125%
London Interbank Offered Rate (LIBOR) | Maximum
Subsequent Event [Line Items]
Basis spread on variable rate	2.00%
Federal Funds Effective Swap Rate
Subsequent Event [Line Items]
Basis spread on variable rate	0.50%
Adjusted LIBOR
Subsequent Event [Line Items]
Basis spread on variable rate	1.00%
Adjusted LIBOR | Minimum
Subsequent Event [Line Items]
Basis spread on variable rate	0.125%
Adjusted LIBOR | Maximum
Subsequent Event [Line Items]
Basis spread on variable rate	1.00%
Revolving Credit Facility
Subsequent Event [Line Items]
Maximum borrowing capacity	$ 1,000,000,000
Term Loan
Subsequent Event [Line Items]
Maximum borrowing capacity	$ 700,000,000

Uncategorized Items - tfx-20190

Label	Element	Value
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 2,110,000
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	(1,321,000)
Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	2,110,000
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ (1,321,000)